Papillomavirus Vaccines
Papillomavirus Infections
Condylomata Acuminata
Papillomaviridae
Human papillomavirus 16
Human papillomavirus 18
Vaccination
Alphapapillomavirus
Vaccines
Viral Vaccines
Papillomavirus E7 Proteins
Licensure
Oncogene Proteins, Viral
Vaccines, Inactivated
Immunization Programs
Vaginal Smears
Immunization Schedule
Health Knowledge, Attitudes, Practice
Human papillomavirus 11
Vaccines, DNA
Vaccines, Synthetic
Tumor Virus Infections
Bacterial Vaccines
Cottontail rabbit papillomavirus
AIDS Vaccines
Human papillomavirus 6
United States
Vaccines, Subunit
Parents
Vaccines, Conjugate
Cervical Intraepithelial Neoplasia
Human papillomavirus 31
Cervix Uteri
Bovine papillomavirus 4
Malaria Vaccines
Health Care Surveys
Meningococcal Vaccines
Cost-Benefit Analysis
Papilloma
Hepatitis B Vaccines
Measles Vaccine
Pertussis Vaccine
Haemophilus Vaccines
BCG Vaccine
Poliovirus Vaccine, Inactivated
Rabies Vaccines
Cholera Vaccines
Molecular Sequence Data
Polymerase Chain Reaction
Socioeconomic Factors
Typhoid-Paratyphoid Vaccines
Smallpox Vaccine
Human Papillomavirus DNA Tests
Adjuvants, Immunologic
Vaccines, Virosome
Chickenpox Vaccine
Diphtheria-Tetanus-Pertussis Vaccine
Keratinocytes
Antipyrine
Mumps Vaccine
Repressor Proteins
Immunization, Secondary
Hepatitis A Vaccines
Immunization
Cell Transformation, Viral
Base Sequence
Carcinoma, Squamous Cell
Gene Expression Regulation, Viral
Dengue Vaccines
Gammapapillomavirus
Colposcopy
Interleukin-12 cDNA skin transfection potentiates human papillomavirus E6 DNA vaccine-induced antitumor immune response. (1/909)
Human papillomaviruses are associated with >90% of all cases of uterine cervical tumors. The E6 and E7 oncoproteins of human papillomavirus are potentially ideal targets of immune therapy for cervical cancer, because their expression is necessary for cellular transformation. Although both E6 and E7 proteins contain numerous predicted cytotoxic T lymphocyte (CTL) epitopes that are capable of binding to human leukocyte antigens, the majority of earlier in vivo tumor rejection studies have focused on E7. We show here that gene gun-mediated skin transfection of plasmid vector encoding the nontransforming, amino-terminal half of E6 resulted in the induction of E6-specific CTL activity and tumor rejection in a murine model. The use of recombinant murine interleukin-12 (rmIL-12) as a vaccine adjuvant has been shown to result in both an enhancement and suppression of immune responses, depending upon the doses of rmIL-12 and the experimental systems used. We demonstrate here that local expression of transgenic mIL-12 at the E6 DNA vaccination site potentiated E6-specific CTL responses and increased vaccine-induced antitumor therapeutic efficacy. Our results indicate that transfection of the mIL-12 gene at the vaccination site may represent an attractive adjuvant for cancer gene immunotherapy. (+info)Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity. (2/909)
A human papillomavirus type 16 E7 DNA vaccine with the open reading frame encoding mutations in two zinc-binding motifs expressed a rapidly degraded E7 protein. This vaccine induced a significantly stronger E7-specific cytotoxic T-lymphocyte response and better tumor protection in mice than did a wild-type E7 DNA vaccine expressing a stable E7 protein. (+info)Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. (3/909)
In this study, we explore a potential vaccine for human papillomavirus (HPV)-induced tumors, using heat shock protein as an adjuvant, a peptide vaccine for safety, and adeno-associated virus (AAV) as a gene delivery vector. The tumor vaccine was devised by constructing a chimeric gene which contained HPV type 16 E7 cytotoxic T-lymphocyte (CTL) epitope DNA (M. C. Feltkamp, H. L. Smits, M. P. Vierboom, R. P. Minnaar, B. M. de Jongh, J. W. Drijfhout, J. ter Schegget, C. J. Melief, and W. M. Kast, Eur. J. Immunol. 23:2242-2249, 1993) fused with the heat shock protein gene as a tumor vaccine delivered via AAV. Our results demonstrate that this vaccine can eliminate tumor cells in syngeneic animals and induce CD4- and CD8-dependent CTL activity in vitro. Moreover, studies with knockout mice with distinct T-cell deficiencies confirm that CTL-induced tumor protection is CD4 and CD8 dependent. Taken together, the evidence indicates that this chimeric gene delivered by AAV has potential as a cervical cancer vaccine. (+info)Viral recombinant vaccines to the E6 and E7 antigens of HPV-16. (4/909)
Most cancerous lesions of the uterine cervix are linked to persistent infections with human papillomaviruses (HPV), most notably HPV-16 or -18. Vaccine-induced immune responses to the HPV early antigens E6 and E7, which contribute to cell transformation and are thus expressed in these cervical cancers, could potentially eradicate malignant cells. We generated recombinant vaccines based on E1-deleted adenovirus human strain 5 or on vaccinia virus strain Copenhagen expressing either the E6 or E7 oncoproteins of HPV-16. The different vaccines were compared in two experimental mouse tumor models employing Balb/c or C57Bl/6 mice. Data presented here demonstrate that depending on the model either CD4(+) or CD8(+) T cells provide protection to tumor cell challenge, resulting in striking differences in the efficacy of the four vaccines under investigation. (+info)A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. (5/909)
Eighteen women with high-grade cervical or vulvar intraepithelial neoplasia who were positive for human papillomavirus (HPV) 16 and were HLA-A2 positive were treated with escalating doses of a vaccine consisting of a 9-amino acid peptide from amino acids 12-20 encoded by the E7 gene emulsified with incomplete Freund's adjuvant. Starting with the eleventh patient, an 8-amino acid peptide 86-93 linked to a helper T-cell epitope peptide with a covalently linked lipid tail was added. Patients with colposcopically and biopsy-proven cervical intraepithelial neoplasia/vulvar intraepithelial neoplasia II/III received four immunizations of increasing doses of the vaccine each 3 weeks apart, followed by a repeat colposcopy and definitive removal of dysplastic tissue 3 weeks after the fourth immunization. Patients were skin tested with the E7 12-20 peptide as well as control candida, mumps, and saline prior to and after the series of immunizations. Peripheral blood mononuclear cells were obtained by leucopheresis prior to and after the series of immunizations for analyses of CTL reactivity to the E7 12-20 and 86-93 epitope sequences. The presence of HPV 16 was assessed by DNA PCR on cervical scrapings and the biopsy specimens after vaccination. Pathology specimens were analyzed before and after vaccination for the presence of dysplasia, and the intralesional infiltrate of CD4/CD8 T-cells and dendritic cells was measured by immunohistochemical staining. Only 3 of 18 patients cleared their dysplasia after vaccine, but an increased S100+ dendritic cell infiltrate was observed in 6 of 6 patients tested. Cytokine release and cytolysis assays to measure E7-specific reactivity revealed increases in 10 of 16 patients tested. No positive delayed type hypersensitivity skin test reactivity was shown in any patient to HPV E7 12-20 before or after vaccinations. Virological assays showed that 12 of 18 patients cleared the virus from cervical scrapings by the fourth vaccine injection, but all biopsy samples were still positive by in situ RNA hybridization after vaccination. Six patients had partial colposcopically measured regression of their cervical intraepithelial neoplastic lesions in addition to the three complete responders. The data establish that a HPV-16 peptide vaccine may have important biological and clinical effects and suggest that future refinements of an HPV vaccine strategy to boost antigen-specific immunity should be explored. (+info)Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. (6/909)
BACKGROUND: Studies in animal models have shown that systemic immunization with a papillomavirus virus-like particle (VLP) vaccine composed of L1, a major structural viral protein, can confer protection against subsequent experimental challenge with the homologous virus. Here we report results of a double-blind, placebo-controlled, dose-escalation trial to evaluate the safety and immunogenicity of a human papillomavirus (HPV) type 16 (HPV16) L1 VLP vaccine in healthy adults. METHODS: Volunteers were given intramuscular injections with placebo or with 10- or 50-microg doses of HPV16 L1 VLP vaccine given without adjuvant or with alum or MF59 as adjuvants at 0, 1, and 4 months. All vaccine recipients were monitored for clinical signs and symptoms for 7 days after each inoculation. Immune responses were measured by an HPV16 L1 VLP-based enzyme-linked immunosorbent assay (ELISA) and by an HPV16 pseudovirion neutralization assay. The antibody titers were given as the reciprocals of the highest dilution showing positive reactivity in each assay. All statistical tests were two-sided. RESULTS: The prevaccination geometric mean ELISA titer for six seropositive individuals was 202 (range, 40--640). All vaccine formulations were well tolerated, and all subjects receiving vaccine seroconverted. Serum antibody responses at 1 month after the third injection were dose dependent in recipients of vaccine without adjuvant or with MF59 but were similar at both doses when alum was the adjuvant. With the higher dose, the geometric means of serum ELISA antibody titers (95% confidence intervals) to purified VLP 1 month after the third injection were as follows: 10,240 (1499 to 69 938) without adjuvant, 10,240 (1114 to 94 145) with MF59, and 2190 (838 to 5723) with alum. Responses of subjects within each group were similar. Neutralizing and ELISA antibody titers were highly correlated (Spearman correlation =.85), confirming that ELISA titers are valid proxies for neutralizing antibodies. CONCLUSIONS: The HPV16 L1 VLP vaccine is well tolerated and is highly immunogenic even without adjuvant, with the majority of the recipients achieving serum antibody titers that were approximately 40-fold higher than what is observed in natural infection. (+info)A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers. (7/909)
Viruslike particles (VLPs) produced from the L1 protein of several papillomaviruses have induced protection from infection after live challenge in animal models. In the present study, the safety and immunogenicity of a human papillomavirus (HPV)--11 L1 VLP candidate vaccine were measured in a phase 1, dose-finding trial in humans. The vaccine was well tolerated and induced high levels of both binding and neutralizing antibodies. Marked increases in lymphoproliferation to HPV--11 L1 antigens were noted after the second vaccination. In addition, lymphoproliferation was induced after vaccination in peripheral blood mononuclear cells (PBMC) stimulated with heterologous L1 VLP antigens of HPV types 6 and 16. Statistically significant increases in HPV antigen--specific interferon--gamma and interleukin-5 production were measured from PBMC culture supernatants. This candidate HPV VLP vaccine induced robust B and T cell responses, and T cell helper epitopes appear to be conserved across HPV types. (+info)Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses. (8/909)
Intestinal mucosa is a portal for many infectious pathogens. Systemic immunization, in general, does not induce a cytotoxic T-lymphocyte (CTL) response at the mucosal surface. Because papillomavirus (PV) naturally infects mucosa and skin, we determined whether PV pseudovirus, i.e., PV-like particles in which unrelated DNA plasmids are packaged, could generate specific mucosal immunity. We found that the pseudovirus that encoded the lymphocytic choriomeningitis virus gp33 epitope induced a stronger CTL response than a DNA vaccine (plasmid) encoding the same epitope given systemically. The virus-like particles that were used to make the pseudoviruses provided an adjuvant effect for induction of CTLs by the DNA vaccine. The PV pseudovirus pseudoinfected mucosal and systemic lymphoid tissues when administered orally. Oral immunization with the pseudovirus encoding human PV type 16 mutant E7 induced mucosal and systemic CTL responses. In comparison, a DNA vaccine encoding E7, when given orally, did not induce a CTL response in intestinal mucosal lymphoid tissue. Further, oral immunization with the human PV pseudovirus encoding E7 protected mice against mucosal challenge with an E7-expressing bovine PV pseudovirus. Thus, PV pseudovirus can be used as a novel vaccine to induce mucosal and systemic CTL responses. (+info)Papillomavirus vaccines are vaccines that have been developed to prevent infection by human papillomaviruses (HPV). HPV is a DNA virus that is capable of infecting the skin and mucous membranes. Certain types of HPV are known to cause cervical cancer, as well as other types of cancer such as anal, penile, vulvar, and oropharyngeal cancers. Other types of HPV can cause genital warts.
There are currently two papillomavirus vaccines that have been approved for use in the United States: Gardasil and Cervarix. Both vaccines protect against the two most common cancer-causing types of HPV (types 16 and 18), which together cause about 70% of cervical cancers. Gardasil also protects against the two most common types of HPV that cause genital warts (types 6 and 11).
Papillomavirus vaccines are given as a series of three shots over a period of six months. They are most effective when given to people before they become sexually active, as this reduces the risk of exposure to HPV. The Centers for Disease Control and Prevention (CDC) recommends that all boys and girls get vaccinated against HPV at age 11 or 12, but the vaccine can be given to people as young as age 9 and as old as age 26.
It is important to note that papillomavirus vaccines do not protect against all types of HPV, and they do not treat existing HPV infections or cervical cancer. They are intended to prevent new HPV infections and the cancers and other diseases that can be caused by HPV.
Papillomavirus infections are a group of diseases caused by various types of human papillomaviruses (HPVs). These viruses infect the skin and mucous membranes, and can cause benign growths such as warts or papillomas, as well as malignant growths like cervical cancer.
There are more than 100 different types of HPVs, and they can be classified into low-risk and high-risk types based on their potential to cause cancer. Low-risk HPV types, such as HPV-6 and HPV-11, commonly cause benign genital warts and respiratory papillomas. High-risk HPV types, such as HPV-16 and HPV-18, are associated with an increased risk of developing cancer, including cervical, anal, penile, vulvar, and oropharyngeal cancers.
HPV infections are typically transmitted through sexual contact, and most sexually active individuals will acquire at least one HPV infection during their lifetime. In many cases, the immune system is able to clear the virus without any symptoms or long-term consequences. However, persistent high-risk HPV infections can lead to the development of cancer over time.
Prevention measures for HPV infections include vaccination against high-risk HPV types, safe sex practices, and regular screening for cervical cancer in women. The HPV vaccine is recommended for both boys and girls aged 11-12 years old, and can also be given to older individuals up to age 45 who have not previously been vaccinated or who have not completed the full series of shots.
'Condylomata Acuminata' is the medical term for genital warts, which are growths or bumps that appear on the genital area. They are caused by certain types of the human papillomavirus (HPV). Genital warts can vary in appearance, and they may be small, flat, and difficult to see or large, cauliflower-like, and easily visible.
The warts can appear on the vulva, vagina, cervix, rectum, anus, penis, or scrotum. They are usually painless but can cause discomfort during sexual intercourse. In some cases, genital warts can lead to serious health problems, such as cervical cancer in women.
It is important to note that not all people with HPV will develop genital warts, and many people with HPV are asymptomatic and unaware they have the virus. The Centers for Disease Control and Prevention (CDC) recommends routine HPV vaccination for both boys and girls aged 11-12 years to prevent HPV infection and related diseases, including genital warts.
Papillomaviridae is a family of small, non-enveloped DNA viruses that primarily infect the epithelial cells of mammals, birds, and reptiles. The name "papillomavirus" comes from the Latin word "papilla," which means nipple or small projection, reflecting the characteristic wart-like growths (papillomas) that these viruses can cause in infected host tissues.
The family Papillomaviridae includes more than 200 distinct papillomavirus types, with each type being defined by its specific DNA sequence. Human papillomaviruses (HPVs), which are the most well-studied members of this family, are associated with a range of diseases, from benign warts and lesions to malignant cancers such as cervical, anal, penile, vulvar, and oropharyngeal cancers.
Papillomaviruses have a circular, double-stranded DNA genome that is approximately 8 kbp in size. The viral genome encodes several early (E) proteins involved in viral replication and oncogenesis, as well as late (L) proteins that form the viral capsid. The life cycle of papillomaviruses is tightly linked to the differentiation program of their host epithelial cells, with productive infection occurring primarily in the differentiated layers of the epithelium.
In summary, Papillomaviridae is a family of DNA viruses that infect epithelial cells and can cause a variety of benign and malignant diseases. Human papillomaviruses are a significant public health concern due to their association with several cancer types.
Uterine cervical neoplasms, also known as cervical cancer or cervical dysplasia, refer to abnormal growths or lesions on the lining of the cervix that have the potential to become cancerous. These growths are usually caused by human papillomavirus (HPV) infection and can be detected through routine Pap smears.
Cervical neoplasms are classified into different grades based on their level of severity, ranging from mild dysplasia (CIN I) to severe dysplasia or carcinoma in situ (CIN III). In some cases, cervical neoplasms may progress to invasive cancer if left untreated.
Risk factors for developing cervical neoplasms include early sexual activity, multiple sexual partners, smoking, and a weakened immune system. Regular Pap smears and HPV testing are recommended for early detection and prevention of cervical cancer.
Human papillomavirus 16 (HPV16) is a specific type of human papillomavirus (HPV). HPV is a DNA virus that infects the skin and mucous membranes, and there are over 200 types of HPV. Some types of HPV can cause warts, while others are associated with an increased risk of certain cancers.
HPV16 is one of the high-risk types of HPV and is strongly associated with several types of cancer, including cervical, anal, penile, vulvar, and oropharyngeal (throat) cancers. HPV16 is responsible for about 50% of all cervical cancers and is the most common high-risk type of HPV found in these cancers.
HPV16 is typically transmitted through sexual contact, and most people who are sexually active will acquire at least one type of HPV at some point in their lives. While HPV infections are often harmless and clear up on their own without causing any symptoms or health problems, high-risk types like HPV16 can lead to cancer if left untreated.
Fortunately, there are vaccines available that protect against HPV16 and other high-risk types of HPV. These vaccines have been shown to be highly effective in preventing HPV-related cancers and precancerous lesions. The Centers for Disease Control and Prevention (CDC) recommends routine HPV vaccination for both boys and girls starting at age 11 or 12, although the vaccine can be given as early as age 9. Catch-up vaccinations are also recommended for older individuals who have not yet been vaccinated.
Human papillomavirus 18 (HPV-18) is a specific type of human papillomavirus (HPV), which is a group of more than 200 related viruses. HPV is named for the warts (papillomas) some types can cause.
HPV-18 is one of the high-risk types of HPV that are linked to several types of cancer, including cervical, anal, vaginal, vulvar, and oropharyngeal (throat) cancers. HPV-18 along with HPV-16 are responsible for about 70% of all cervical cancers.
HPV is passed from one person to another during skin-to-skin contact, usually during sexual activity. Most sexually active people will have an HPV infection at some point in their lives, but most will never know it because the virus often causes no symptoms and goes away on its own. However, when HPV doesn't go away, it can cause serious health problems, including cancer.
There are vaccines available to protect against HPV-18 and other high-risk types of HPV. The Centers for Disease Control and Prevention (CDC) recommends that all boys and girls get the HPV vaccine at age 11 or 12, but it can be given as early as age 9 and until age 26 for those who have not yet received it. The vaccine is most effective when given before becoming sexually active.
Vaccination is a simple, safe, and effective way to protect people against harmful diseases, before they come into contact with them. It uses your body's natural defenses to build protection to specific infections and makes your immune system stronger.
A vaccination usually contains a small, harmless piece of a virus or bacteria (or toxins produced by these germs) that has been made inactive or weakened so it won't cause the disease itself. This piece of the germ is known as an antigen. When the vaccine is introduced into the body, the immune system recognizes the antigen as foreign and produces antibodies to fight it.
If a person then comes into contact with the actual disease-causing germ, their immune system will recognize it and immediately produce antibodies to destroy it. The person is therefore protected against that disease. This is known as active immunity.
Vaccinations are important for both individual and public health. They prevent the spread of contagious diseases and protect vulnerable members of the population, such as young children, the elderly, and people with weakened immune systems who cannot be vaccinated or for whom vaccination is not effective.
Alphapapillomavirus is a genus of Papillomaviridae, a family of small, non-enveloped DNA viruses that infect the skin and mucous membranes of humans and other animals. Members of this genus are known to cause various types of benign and malignant tumors in humans, including skin warts, genital warts, and cancers of the cervix, anus, penis, vulva, and oropharynx.
The Alphapapillomavirus genus is further divided into several species, each containing multiple types or strains of the virus. Some of the most well-known and studied types of Alphapapillomavirus include:
* Human papillomavirus (HPV) type 16 and 18, which are associated with a high risk of cervical cancer and other anogenital cancers
* HPV type 6 and 11, which are commonly found in genital warts and recurrent respiratory papillomatosis
* HPV types 31, 33, 45, 52, and 58, which are also associated with an increased risk of cervical cancer and other malignancies.
Preventive measures such as vaccination against high-risk HPV types have been shown to significantly reduce the incidence of cervical cancer and other HPV-related diseases. Regular screening for cervical cancer and other precancerous lesions is also an important part of prevention and early detection.
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. It typically contains an agent that resembles the disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it encounters in the future.
Vaccines can be prophylactic (to prevent or ameliorate the effects of a future infection by a natural or "wild" pathogen), or therapeutic (to fight disease that is already present). The administration of vaccines is called vaccination. Vaccinations are generally administered through needle injections, but can also be administered by mouth or sprayed into the nose.
The term "vaccine" comes from Edward Jenner's 1796 use of cowpox to create immunity to smallpox. The first successful vaccine was developed in 1796 by Edward Jenner, who showed that milkmaids who had contracted cowpox did not get smallpox. He reasoned that exposure to cowpox protected against smallpox and tested his theory by injecting a boy with pus from a cowpox sore and then exposing him to smallpox, which the boy did not contract. The word "vaccine" is derived from Variolae vaccinae (smallpox of the cow), the term devised by Jenner to denote cowpox. He used it in 1798 during a conversation with a fellow physician and later in the title of his 1801 Inquiry.
A viral vaccine is a biological preparation that introduces your body to a specific virus in a way that helps your immune system build up protection against the virus without causing the illness. Viral vaccines can be made from weakened or inactivated forms of the virus, or parts of the virus such as proteins or sugars. Once introduced to the body, the immune system recognizes the virus as foreign and produces an immune response, including the production of antibodies. These antibodies remain in the body and provide immunity against future infection with that specific virus.
Viral vaccines are important tools for preventing infectious diseases caused by viruses, such as influenza, measles, mumps, rubella, polio, hepatitis A and B, rabies, rotavirus, chickenpox, shingles, and some types of cancer. Vaccination programs have led to the control or elimination of many infectious diseases that were once common.
It's important to note that viral vaccines are not effective against bacterial infections, and separate vaccines must be developed for each type of virus. Additionally, because viruses can mutate over time, it is necessary to update some viral vaccines periodically to ensure continued protection.
Papillomavirus E7 proteins are small, viral regulatory proteins encoded by the E7 gene in papillomaviruses (HPVs). These proteins play a crucial role in the life cycle of HPVs and are associated with the development of various types of cancer, most notably cervical cancer.
The E7 protein functions as a transcriptional activator and can bind to and degrade the retinoblastoma protein (pRb), which is a tumor suppressor. By binding to and inactivating pRb, E7 promotes the expression of genes required for cell cycle progression, leading to uncontrolled cell growth and proliferation.
E7 proteins are also capable of inducing genetic alterations, such as chromosomal instability and DNA damage, which can contribute to the development of cancer. Additionally, E7 has been shown to inhibit apoptosis (programmed cell death) and promote angiogenesis (the formation of new blood vessels), further contributing to tumor growth and progression.
Overall, Papillomavirus E7 proteins are important oncogenic factors that play a central role in the development of HPV-associated cancers.
Bovine papillomavirus 1 (BPV-1) is a species of papillomavirus that primarily infects cattle, causing benign warts or papillomas in the skin and mucous membranes. It is not known to infect humans or cause disease in humans. BPV-1 is closely related to other papillomaviruses that can cause cancer in animals, but its role in human cancer is unclear.
BPV-1 is a double-stranded DNA virus that replicates in the nucleus of infected cells. It encodes several early and late proteins that are involved in viral replication and the transformation of host cells. BPV-1 has been extensively studied as a model system for understanding the molecular mechanisms of papillomavirus infection and oncogenesis.
In addition to its role in animal health, BPV-1 has also been used as a tool in biomedical research. For example, it can be used to transform cells in culture, providing a valuable resource for studying the properties of cancer cells and testing potential therapies. However, it is important to note that BPV-1 is not known to cause human disease and should not be used in any therapeutic context involving humans.
I'm sorry for any confusion, but "Mandatory Programs" is not a medical term or concept. It is a more general term that can be used in various contexts, including computer science, law, and policy-making. In the context of medicine or healthcare, it might refer to programs or initiatives that are required by law or regulation, but there is no specific medical definition for this term. If you have a specific context in mind, I'd be happy to help further clarify if I can!
Licensure is the process by which a government regulatory agency grants a license to a physician (or other healthcare professional) to practice medicine (or provide healthcare services) in a given jurisdiction. The licensing process typically requires the completion of specific educational and training requirements, passing written and/or practical exams, and meeting other state-specific criteria.
The purpose of licensure is to ensure that healthcare professionals meet minimum standards of competence and safety in order to protect the public. Licensure laws vary by state, so a physician who is licensed to practice medicine in one state may not be able to practice in another state without obtaining additional licensure.
Oncogene proteins, viral, are cancer-causing proteins that are encoded by the genetic material (DNA or RNA) of certain viruses. These viral oncogenes can be acquired through infection with retroviruses, such as human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), and certain types of papillomaviruses and polyomaviruses.
When these viruses infect host cells, they can integrate their genetic material into the host cell's genome, leading to the expression of viral oncogenes. These oncogenes may then cause uncontrolled cell growth and division, ultimately resulting in the formation of tumors or cancers. The process by which viruses contribute to cancer development is complex and involves multiple steps, including the alteration of signaling pathways that regulate cell proliferation, differentiation, and survival.
Examples of viral oncogenes include the v-src gene found in the Rous sarcoma virus (RSV), which causes chicken sarcoma, and the E6 and E7 genes found in human papillomaviruses (HPVs), which are associated with cervical cancer and other anogenital cancers. Understanding viral oncogenes and their mechanisms of action is crucial for developing effective strategies to prevent and treat virus-associated cancers.
Inactivated vaccines, also known as killed or non-live vaccines, are created by using a version of the virus or bacteria that has been grown in a laboratory and then killed or inactivated with chemicals, heat, or radiation. This process renders the organism unable to cause disease, but still capable of stimulating an immune response when introduced into the body.
Inactivated vaccines are generally considered safer than live attenuated vaccines since they cannot revert back to a virulent form and cause illness. However, they may require multiple doses or booster shots to maintain immunity because the immune response generated by inactivated vaccines is not as robust as that produced by live vaccines. Examples of inactivated vaccines include those for hepatitis A, rabies, and influenza (inactivated flu vaccine).
In the context of medical ethics and law, "intention" refers to the purpose or aim behind an action. It is a mental state that is formed when an individual consciously decides to perform a certain act or achieve a specific goal. In medical procedures and treatments, healthcare providers must consider their intentions and ensure that they are acting in the best interest of the patient, with the primary intent being to benefit the patient's health and well-being.
In some cases, such as in end-of-life care, determining the intention behind a medical intervention can be critical in assessing its ethical and legal implications. For example, if a healthcare provider administers pain relief medication with the primary intention of alleviating the patient's suffering, rather than shortening their life, then this is considered ethically and legally acceptable. However, if the primary intention is to hasten the patient's death, then this would be considered unacceptable and potentially illegal.
Therefore, understanding and clarifying the intention behind medical actions is an essential aspect of ensuring that healthcare providers act ethically and within the bounds of the law.
Immunization programs, also known as vaccination programs, are organized efforts to administer vaccines to populations or communities in order to protect individuals from vaccine-preventable diseases. These programs are typically implemented by public health agencies and involve the planning, coordination, and delivery of immunizations to ensure that a high percentage of people are protected against specific infectious diseases.
Immunization programs may target specific age groups, such as infants and young children, or populations at higher risk of certain diseases, such as travelers, healthcare workers, or individuals with weakened immune systems. The goals of immunization programs include controlling and eliminating vaccine-preventable diseases, reducing the morbidity and mortality associated with these diseases, and protecting vulnerable populations from outbreaks and epidemics.
Immunization programs may be delivered through a variety of settings, including healthcare facilities, schools, community centers, and mobile clinics. They often involve partnerships between government agencies, healthcare providers, non-governmental organizations, and communities to ensure that vaccines are accessible, affordable, and acceptable to the populations they serve. Effective immunization programs require strong leadership, adequate funding, robust data systems, and ongoing monitoring and evaluation to assess their impact and identify areas for improvement.
A vaginal smear, also known as a Pap test or Pap smear, is a medical procedure in which a sample of cells is collected from the cervix (the lower part of the uterus that opens into the vagina) and examined under a microscope. The purpose of this test is to detect abnormal cells, including precancerous changes, that may indicate the presence of cervical cancer or other conditions such as infections or inflammation.
During the procedure, a speculum is inserted into the vagina to allow the healthcare provider to visualize the cervix. A spatula or brush is then used to gently scrape cells from the surface of the cervix. The sample is spread onto a microscope slide and sent to a laboratory for analysis.
Regular Pap smears are recommended for women as part of their routine healthcare, as they can help detect abnormalities at an early stage when they are more easily treated. The frequency of Pap smears may vary depending on age, medical history, and other factors. It is important to follow the recommendations of a healthcare provider regarding the timing and frequency of Pap smears.
An immunization schedule is a series of planned dates when a person, usually a child, should receive specific vaccines in order to be fully protected against certain preventable diseases. The schedule is developed based on scientific research and recommendations from health organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).
The immunization schedule outlines which vaccines are recommended, the number of doses required, the age at which each dose should be given, and the minimum amount of time that must pass between doses. The schedule may vary depending on factors such as the individual's age, health status, and travel plans.
Immunization schedules are important for ensuring that individuals receive timely protection against vaccine-preventable diseases, and for maintaining high levels of immunity in populations, which helps to prevent the spread of disease. It is important to follow the recommended immunization schedule as closely as possible to ensure optimal protection.
"Health Knowledge, Attitudes, and Practices" (HKAP) is a term used in public health to refer to the knowledge, beliefs, assumptions, and behaviors that individuals possess or engage in that are related to health. Here's a brief definition of each component:
1. Health Knowledge: Refers to the factual information and understanding that individuals have about various health-related topics, such as anatomy, physiology, disease processes, and healthy behaviors.
2. Attitudes: Represent the positive or negative evaluations, feelings, or dispositions that people hold towards certain health issues, practices, or services. These attitudes can influence their willingness to adopt and maintain healthy behaviors.
3. Practices: Encompass the specific actions or habits that individuals engage in related to their health, such as dietary choices, exercise routines, hygiene practices, and use of healthcare services.
HKAP is a multidimensional concept that helps public health professionals understand and address various factors influencing individual and community health outcomes. By assessing and addressing knowledge gaps, negative attitudes, or unhealthy practices, interventions can be designed to promote positive behavior change and improve overall health status.
Human papillomavirus type 11 (HPV-11) is a specific type of human papillomavirus that is known to cause benign, or noncancerous, growths called papillomas or warts on the skin and mucous membranes. HPV-11 is one of several types of HPV that are classified as low-risk because they are rarely associated with cancer.
HPV-11 is primarily transmitted through sexual contact and can infect the genital area, leading to the development of genital warts. In some cases, HPV-11 infection may also cause respiratory papillomatosis, a rare condition in which benign growths develop in the airways, including the throat and lungs.
HPV-11 is preventable through vaccination with the human papillomavirus vaccine, which protects against several low-risk and high-risk types of HPV. It is important to note that while HPV-11 is not associated with cancer, other high-risk types of HPV can cause cervical, anal, and oral cancers, so vaccination is still recommended for individuals who are sexually active or plan to become sexually active.
I could not find a specific medical definition for "Vaccines, DNA." However, I can provide you with some information about DNA vaccines.
DNA vaccines are a type of vaccine that uses genetically engineered DNA to stimulate an immune response in the body. They work by introducing a small piece of DNA into the body that contains the genetic code for a specific antigen (a substance that triggers an immune response). The cells of the body then use this DNA to produce the antigen, which prompts the immune system to recognize and attack it.
DNA vaccines have several advantages over traditional vaccines. They are relatively easy to produce, can be stored at room temperature, and can be designed to protect against a wide range of diseases. Additionally, because they use DNA to stimulate an immune response, DNA vaccines do not require the growth and culture of viruses or bacteria, which can make them safer than traditional vaccines.
DNA vaccines are still in the experimental stages, and more research is needed to determine their safety and effectiveness. However, they have shown promise in animal studies and are being investigated as a potential tool for preventing a variety of infectious diseases, including influenza, HIV, and cancer.
Patient acceptance of health care refers to the willingness and ability of a patient to follow and engage in a recommended treatment plan or healthcare regimen. This involves understanding the proposed medical interventions, considering their potential benefits and risks, and making an informed decision to proceed with the recommended course of action.
The factors that influence patient acceptance can include:
1. Patient's understanding of their condition and treatment options
2. Trust in their healthcare provider
3. Personal beliefs and values related to health and illness
4. Cultural, linguistic, or socioeconomic barriers
5. Emotional responses to the diagnosis or proposed treatment
6. Practical considerations, such as cost, time commitment, or potential side effects
Healthcare providers play a crucial role in facilitating patient acceptance by clearly communicating information, addressing concerns and questions, and providing support throughout the decision-making process. Encouraging shared decision-making and tailoring care plans to individual patient needs and preferences can also enhance patient acceptance of health care.
Synthetic vaccines are artificially produced, designed to stimulate an immune response and provide protection against specific diseases. Unlike traditional vaccines that are derived from weakened or killed pathogens, synthetic vaccines are created using synthetic components, such as synthesized viral proteins, DNA, or RNA. These components mimic the disease-causing agent and trigger an immune response without causing the actual disease. The use of synthetic vaccines offers advantages in terms of safety, consistency, and scalability in production, making them valuable tools for preventing infectious diseases.
Anus neoplasms refer to abnormal growths or tumors in the anus, which is the opening at the end of the digestive tract where solid waste leaves the body. These growths can be benign (non-cancerous) or malignant (cancerous). Common types of anus neoplasms include squamous cell carcinoma, adenocarcinoma, and melanoma.
Squamous cell carcinoma is the most common type of anus cancer, accounting for about 80% of all cases. It begins in the squamous cells that line the anal canal and can spread to other parts of the body if left untreated.
Adenocarcinoma is a less common type of anus cancer that arises from glandular cells in the anus. This type of cancer is often associated with long-standing inflammatory conditions, such as anal fistulas or ulcerative colitis.
Melanoma is a rare form of skin cancer that can also occur in the anus. It develops from pigment-producing cells called melanocytes and tends to be aggressive with a high risk of spreading to other parts of the body.
Other less common types of anus neoplasms include basal cell carcinoma, sarcoma, and lymphoma. Treatment options for anus neoplasms depend on the type, stage, and location of the tumor, as well as the patient's overall health.
Combined vaccines are defined in medical terms as vaccines that contain two or more antigens from different diseases, which are given to provide protection against multiple diseases at the same time. This approach reduces the number of injections required and simplifies the immunization schedule, especially during early childhood. Examples of combined vaccines include:
1. DTaP-Hib-IPV (e.g., Pentacel): A vaccine that combines diphtheria, tetanus, pertussis (whooping cough), Haemophilus influenzae type b (Hib) disease, and poliovirus components in one injection to protect against these five diseases.
2. MMRV (e.g., ProQuad): A vaccine that combines measles, mumps, rubella, and varicella (chickenpox) antigens in a single injection to provide immunity against all four diseases.
3. HepA-HepB (e.g., Twinrix): A vaccine that combines hepatitis A and hepatitis B antigens in one injection, providing protection against both types of hepatitis.
4. MenACWY-TT (e.g., MenQuadfi): A vaccine that combines four serogroups of meningococcal bacteria (A, C, W, Y) with tetanus toxoid as a carrier protein in one injection for the prevention of invasive meningococcal disease caused by these serogroups.
5. PCV13-PPSV23 (e.g., Vaxneuvance): A vaccine that combines 13 pneumococcal serotypes with PPSV23, providing protection against a broader range of pneumococcal diseases in adults aged 18 years and older.
Combined vaccines have been thoroughly tested for safety and efficacy to ensure they provide a strong immune response and an acceptable safety profile. They are essential tools in preventing various infectious diseases and improving overall public health.
A tumor virus infection is a condition in which a person's cells become cancerous or transformed due to the integration and disruption of normal cellular functions by a viral pathogen. These viruses are also known as oncoviruses, and they can cause tumors or cancer by altering the host cell's genetic material, promoting uncontrolled cell growth and division, evading immune surveillance, and inhibiting apoptosis (programmed cell death).
Examples of tumor viruses include:
1. DNA tumor viruses: These are double-stranded DNA viruses that can cause cancer in humans. Examples include human papillomavirus (HPV), hepatitis B virus (HBV), and Merkel cell polyomavirus (MCV).
2. RNA tumor viruses: Also known as retroviruses, these single-stranded RNA viruses can cause cancer in humans. Examples include human T-cell leukemia virus type 1 (HTLV-1) and human immunodeficiency virus (HIV).
Tumor virus infections are responsible for approximately 15-20% of all cancer cases worldwide, making them a significant public health concern. Prevention strategies, such as vaccination against HPV and HBV, have been shown to reduce the incidence of associated cancers.
Bacterial vaccines are types of vaccines that are created using bacteria or parts of bacteria as the immunogen, which is the substance that triggers an immune response in the body. The purpose of a bacterial vaccine is to stimulate the immune system to develop protection against specific bacterial infections.
There are several types of bacterial vaccines, including:
1. Inactivated or killed whole-cell vaccines: These vaccines contain entire bacteria that have been killed or inactivated through various methods, such as heat or chemicals. The bacteria can no longer cause disease, but they still retain the ability to stimulate an immune response.
2. Subunit, protein, or polysaccharide vaccines: These vaccines use specific components of the bacterium, such as proteins or polysaccharides, that are known to trigger an immune response. By using only these components, the vaccine can avoid using the entire bacterium, which may reduce the risk of adverse reactions.
3. Live attenuated vaccines: These vaccines contain live bacteria that have been weakened or attenuated so that they cannot cause disease but still retain the ability to stimulate an immune response. This type of vaccine can provide long-lasting immunity, but it may not be suitable for people with weakened immune systems.
Bacterial vaccines are essential tools in preventing and controlling bacterial infections, reducing the burden of diseases such as tuberculosis, pneumococcal disease, meningococcal disease, and Haemophilus influenzae type b (Hib) disease. They work by exposing the immune system to a harmless form of the bacteria or its components, which triggers the production of antibodies and memory cells that can recognize and fight off future infections with that same bacterium.
It's important to note that while vaccines are generally safe and effective, they may cause mild side effects such as pain, redness, or swelling at the injection site, fever, or fatigue. Serious side effects are rare but can occur, so it's essential to consult with a healthcare provider before receiving any vaccine.
Cottontail rabbit papillomavirus (CRPV) is a type of virus that belongs to the family Papovaviridae and the genus *Alpha papillomavirus*. It primarily infects cottontail rabbits, causing the development of warts or papillomas on their skin. These growths are typically found on the ears, face, and genital areas of the rabbits.
The CRPV virus is transmitted through direct contact with an infected rabbit or through contaminated environments. The virus enters the body through small cuts or abrasions in the skin and infects the epithelial cells, leading to the development of warts.
While CRPV primarily affects cottontail rabbits, it has been used as a model system for studying papillomavirus infections and related diseases in humans. The virus shares many similarities with human papillomaviruses (HPVs), including the ability to cause cancer in certain circumstances.
It is important to note that CRPV is not a threat to humans or other animals outside of its natural host range, which includes cottontail rabbits.
Viral DNA refers to the genetic material present in viruses that consist of DNA as their core component. Deoxyribonucleic acid (DNA) is one of the two types of nucleic acids that are responsible for storing and transmitting genetic information in living organisms. Viruses are infectious agents much smaller than bacteria that can only replicate inside the cells of other organisms, called hosts.
Viral DNA can be double-stranded (dsDNA) or single-stranded (ssDNA), depending on the type of virus. Double-stranded DNA viruses have a genome made up of two complementary strands of DNA, while single-stranded DNA viruses contain only one strand of DNA.
Examples of dsDNA viruses include Adenoviruses, Herpesviruses, and Poxviruses, while ssDNA viruses include Parvoviruses and Circoviruses. Viral DNA plays a crucial role in the replication cycle of the virus, encoding for various proteins necessary for its multiplication and survival within the host cell.
An AIDS vaccine is a type of preventive vaccine that aims to stimulate the immune system to produce an effective response against the human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS). The goal of an AIDS vaccine is to induce the production of immune cells and proteins that can recognize and eliminate HIV-infected cells, thereby preventing the establishment of a persistent infection.
Despite decades of research, there is still no licensed AIDS vaccine available. This is due in part to the unique challenges posed by HIV, which has a high mutation rate and can rapidly evolve to evade the immune system's defenses. However, several promising vaccine candidates are currently being tested in clinical trials around the world, and researchers continue to explore new approaches and strategies for developing an effective AIDS vaccine.
Human papillomavirus 6 (HPV-6) is a type of human papillomavirus (HPV), which is a double-stranded DNA virus belonging to the Papillomaviridae family. HPV-6 is one of the low-risk types of HPV that primarily causes benign, self-limiting epithelial lesions, such as genital warts (condyloma acuminata) and respiratory papillomas.
HPV-6 is sexually transmitted and can infect both males and females. Infection with HPV-6 may not always cause symptoms or noticeable lesions, but when it does, the most common manifestation is genital warts. These warts can appear as small, flesh-colored bumps or growths on the genitals, anus, or surrounding skin. They can be flat or raised, single or multiple, and sometimes cluster together in a cauliflower-like shape.
Although HPV-6 is generally considered low risk, it has been associated with rare cases of recurrent respiratory papillomatosis (RRP), a condition characterized by the growth of benign tumors in the respiratory tract. RRP can cause hoarseness, noisy breathing, and difficulty swallowing, and may require surgical intervention to manage.
Preventive measures against HPV-6 include vaccination with approved HPV vaccines (Gardasil and Gardasil 9) that protect against HPV-6, as well as other low-risk and high-risk types of HPV. Safe sexual practices, such as using condoms, can also reduce the risk of transmission but do not provide complete protection since HPV can infect areas not covered by condoms.
I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!
A subunit vaccine is a type of vaccine that contains a specific piece or component of the microorganism (such as a protein, sugar, or part of the bacterial outer membrane), instead of containing the entire organism. This piece of the microorganism is known as an antigen, and it stimulates an immune response in the body, allowing the development of immunity against the targeted infection without introducing the risk of disease associated with live vaccines.
Subunit vaccines offer several advantages over other types of vaccines. They are generally safer because they do not contain live or weakened microorganisms, making them suitable for individuals with weakened immune systems or specific medical conditions that prevent them from receiving live vaccines. Additionally, subunit vaccines can be designed to focus on the most immunogenic components of a pathogen, potentially leading to stronger and more targeted immune responses.
Examples of subunit vaccines include the Hepatitis B vaccine, which contains a viral protein, and the Haemophilus influenzae type b (Hib) vaccine, which uses pieces of the bacterial polysaccharide capsule. These vaccines have been crucial in preventing serious infectious diseases and reducing associated complications worldwide.
I'm sorry for any confusion, but "parents" is not a term that has a medical definition. In general usage, parents are the two people (typically) who bring up and care for a child, or who have given birth to or adopted a child. They are responsible for the child's housing, food, clothing, education, and medical care. Is there a specific medical or healthcare-related context you had in mind? I would be happy to help further if I can.
Conjugate vaccines are a type of vaccine that combines a part of a bacterium with a protein or other substance to boost the body's immune response to the bacteria. The bacterial component is usually a polysaccharide, which is a long chain of sugars that makes up part of the bacterial cell wall.
By itself, a polysaccharide is not very immunogenic, meaning it does not stimulate a strong immune response. However, when it is conjugated or linked to a protein or other carrier molecule, it becomes much more immunogenic and can elicit a stronger and longer-lasting immune response.
Conjugate vaccines are particularly effective in protecting against bacterial infections that affect young children, such as Haemophilus influenzae type b (Hib) and pneumococcal disease. These vaccines have been instrumental in reducing the incidence of these diseases and their associated complications, such as meningitis and pneumonia.
Overall, conjugate vaccines work by mimicking a natural infection and stimulating the immune system to produce antibodies that can protect against future infections with the same bacterium. By combining a weakly immunogenic polysaccharide with a protein carrier, these vaccines can elicit a stronger and more effective immune response, providing long-lasting protection against bacterial infections.
Cervical intraepithelial neoplasia (CIN) is a term used to describe the abnormal growth and development of cells on the surface of the cervix. These changes are usually caused by human papillomavirus (HPV) infection, which is a common sexually transmitted infection. CIN is not cancer, but it can develop into cancer if left untreated.
The term "intraepithelial" refers to the fact that the abnormal cells are found in the epithelium, or the lining of the cervix. The term "neoplasia" means abnormal growth or development of cells. CIN is further classified into three grades based on the severity of the cell changes:
* CIN 1: Mild dysplasia (abnormal cell growth) affecting the lower third of the epithelium.
* CIN 2: Moderate dysplasia affecting the lower two-thirds of the epithelium.
* CIN 3: Severe dysplasia or carcinoma in situ, which means that the abnormal cells are found in the full thickness of the epithelium and have a high risk of progressing to invasive cancer if not treated.
It's important to note that CIN can regress on its own without treatment, especially in younger women. However, some cases may progress to invasive cervical cancer if left untreated. Regular Pap testing is recommended to detect and monitor any abnormal cell changes in the cervix. If CIN is detected, further diagnostic procedures such as a colposcopy or biopsy may be performed to determine the extent of the abnormality and guide treatment decisions.
Human papillomavirus 31 (HPV31) is a specific type of human papillomavirus (HPV), which is a DNA virus that infects the skin and mucous membranes. HPV31 is one of the high-risk types of HPV, meaning it has a higher association with the development of certain cancers, particularly cervical cancer.
HPV31, like other HPV types, can cause various clinical manifestations, such as anogenital warts and precancerous lesions in the cervix, anus, vulva, vagina, and penis. Infection with HPV31 may lead to abnormal Pap test results and potentially increase the risk of developing cervical cancer if left untreated.
Prevention strategies include HPV vaccination, which protects against several high-risk types of HPV, including HPV31. Regular screening for cervical cancer through Pap tests and, when necessary, HPV testing is also crucial in early detection and treatment of precancerous lesions caused by HPV infections.
The cervix uteri, often simply referred to as the cervix, is the lower part of the uterus (womb) that connects to the vagina. It has an opening called the external os through which menstrual blood exits the uterus and sperm enters during sexual intercourse. During childbirth, the cervix dilates or opens to allow for the passage of the baby through the birth canal.
Bovine Papillomavirus 4 (BPV-4) is a species of papillomavirus that primarily infects cattle, causing benign warts and papillomas in the skin and mucous membranes. It is not known to infect humans or play a role in human health. BPV-4, like other papillomaviruses, contains a circular double-stranded DNA genome and replicates in the nucleus of infected host cells.
It's worth noting that while BPV-4 is not a human pathogen, related papillomaviruses are known to cause various types of cancer in humans, including cervical, anal, penile, and oropharyngeal cancers. Research on BPV-4 and other animal papillomaviruses has contributed significantly to our understanding of the biology and pathogenesis of human papillomaviruses (HPVs).
Healthcare disparities refer to differences in the quality, accessibility, and outcomes of healthcare that are systematically related to social or economic disadvantage. These disparities may exist between different racial, ethnic, socioeconomic, gender, sexual orientation, geographic, or disability status groups. They can result from a complex interplay of factors including provider bias, patient-provider communication, health system policies, and structural racism, among others. Healthcare disparities often lead to worse health outcomes and reduced quality of life for disadvantaged populations.
Malaria vaccines are biological preparations that induce immunity against malaria parasites, thereby preventing or reducing the severity of malaria disease. They typically contain antigens (proteins or other molecules derived from the parasite) that stimulate an immune response in the recipient, enabling their body to recognize and neutralize the pathogen upon exposure.
The most advanced malaria vaccine candidate is RTS,S/AS01 (Mosquirix), which targets the Plasmodium falciparum parasite's circumsporozoite protein (CSP). This vaccine has shown partial protection in clinical trials, reducing the risk of severe malaria and hospitalization in young children by about 30% over four years. However, it does not provide complete immunity, and additional research is ongoing to develop more effective vaccines against malaria.
Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.
Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.
There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.
In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.
Health care surveys are research tools used to systematically collect information from a population or sample regarding their experiences, perceptions, and knowledge of health services, health outcomes, and various other health-related topics. These surveys typically consist of standardized questionnaires that cover specific aspects of healthcare, such as access to care, quality of care, patient satisfaction, health disparities, and healthcare costs. The data gathered from health care surveys are used to inform policy decisions, improve healthcare delivery, identify best practices, allocate resources, and monitor the health status of populations. Health care surveys can be conducted through various modes, including in-person interviews, telephone interviews, mail-in questionnaires, or online platforms.
Warts are small, rough growths on the skin or mucous membranes caused by one of several types of human papillomavirus (HPV). They can appear anywhere on the body but most often occur on the hands, fingers, and feet. Warts are benign, non-cancerous growths, but they can be unsightly, uncomfortable, or painful, depending on their location and size.
Warts are caused by HPV infecting the top layer of skin, usually through a small cut or scratch. The virus triggers an overproduction of keratin, a protein in the skin, leading to the formation of a hard, rough growth. Warts can vary in appearance depending on their location and type, but they are generally round or irregularly shaped, with a rough surface that may be flat or slightly raised. They may also contain small black dots, which are actually tiny blood vessels that have clotted.
Warts are contagious and can spread from person to person through direct skin-to-skin contact or by sharing personal items such as towels or razors. They can also be spread by touching a wart and then touching another part of the body. Warts may take several months to develop after exposure to HPV, so it may not always be clear when or how they were contracted.
There are several types of warts, including common warts, plantar warts (which occur on the soles of the feet), flat warts (which are smaller and smoother than other types of warts), and genital warts (which are sexually transmitted). While most warts are harmless and will eventually go away on their own, some may require medical treatment if they are causing discomfort or are unsightly. Treatment options for warts include topical medications, cryotherapy (freezing the wart with liquid nitrogen), and surgical removal.
Meningococcal vaccines are vaccines that protect against Neisseria meningitidis, a type of bacteria that can cause serious infections such as meningitis (inflammation of the lining of the brain and spinal cord) and septicemia (bloodstream infection). There are several types of meningococcal vaccines available, including conjugate vaccines and polysaccharide vaccines. These vaccines work by stimulating the immune system to produce antibodies that can protect against the different serogroups of N. meningitidis, including A, B, C, Y, and W-135. The specific type of vaccine used and the number of doses required may depend on a person's age, health status, and other factors. Meningococcal vaccines are recommended for certain high-risk populations, such as infants, young children, adolescents, and people with certain medical conditions, as well as for travelers to areas where meningococcal disease is common.
Cost-benefit analysis (CBA) is a systematic process used to compare the costs and benefits of different options to determine which one provides the greatest net benefit. In a medical context, CBA can be used to evaluate the value of medical interventions, treatments, or policies by estimating and monetizing all the relevant costs and benefits associated with each option.
The costs included in a CBA may include direct costs such as the cost of the intervention or treatment itself, as well as indirect costs such as lost productivity or time away from work. Benefits may include improved health outcomes, reduced morbidity or mortality, and increased quality of life.
Once all the relevant costs and benefits have been identified and quantified, they are typically expressed in monetary terms to allow for a direct comparison. The option with the highest net benefit (i.e., the difference between total benefits and total costs) is considered the most cost-effective.
It's important to note that CBA has some limitations and can be subject to various biases and assumptions, so it should be used in conjunction with other evaluation methods to ensure a comprehensive understanding of the value of medical interventions or policies.
DNA probes for HPV (Human Papillomavirus) are specific DNA sequences that are used in diagnostic tests to detect and identify the presence of HPV DNA in a sample. HPV is a viral infection that can cause various types of cancer, including cervical, anal, and oropharyngeal cancers.
DNA probes for HPV work by binding to complementary sequences of HPV DNA in the sample. This binding can be detected and measured using various methods, such as hybridization, amplification, or labeling techniques. The use of DNA probes for HPV can help identify the specific type of HPV that is present in a sample, which can inform clinical management and treatment decisions.
It's important to note that not all HPV infections lead to cancer, and most HPV infections resolve on their own without causing any harm. However, certain high-risk types of HPV are more strongly associated with an increased risk of developing cancer, so identifying the presence and type of HPV infection can be useful for monitoring and managing patients who may be at higher risk.
A papilloma is a benign (noncancerous) tumor that grows on a stalk, often appearing as a small cauliflower-like growth. It can develop in various parts of the body, but when it occurs in the mucous membranes lining the respiratory, digestive, or genitourinary tracts, they are called squamous papillomas. The most common type is the skin papilloma, which includes warts. They are usually caused by human papillomavirus (HPV) infection and can be removed through various medical procedures if they become problematic or unsightly.
Uterine cervical diseases refer to conditions that affect the cervix, which is the lower part of the uterus that opens into the vagina. These diseases can range from minor abnormalities to more serious conditions, such as:
1. Cervical dysplasia: This is a precancerous condition characterized by the presence of abnormal cells on the cervix. It is usually caused by the human papillomavirus (HPV) and can be detected through a Pap test.
2. Cervical cancer: This is a malignant tumor that develops in the cervical tissue. The most common type of cervical cancer is squamous cell carcinoma, which arises from the cells lining the surface of the cervix.
3. Cervicitis: This is an inflammation of the cervix, which can be caused by infections, irritants, or allergies. Symptoms may include vaginal discharge, pain, and bleeding.
4. Cervical polyps: These are benign growths that develop on the cervix. They are usually small and asymptomatic but can cause abnormal vaginal bleeding or discharge.
5. Cervical incompetence: This is a condition where the cervix begins to open prematurely during pregnancy, leading to a risk of miscarriage or preterm labor.
It's important to note that regular screening and early detection can help prevent or manage many cervical diseases, including cervical cancer.
"Hepatitis B vaccines are vaccines that prevent infection caused by the hepatitis B virus. They work by introducing a small and harmless piece of the virus to your body, which triggers your immune system to produce antibodies to fight off the infection. These antibodies remain in your body and provide protection if you are exposed to the real hepatitis B virus in the future.
The hepatitis B vaccine is typically given as a series of three shots over a six-month period. It is recommended for all infants, children and adolescents who have not previously been vaccinated, as well as for adults who are at increased risk of infection, such as healthcare workers, people who inject drugs, and those with certain medical conditions.
It's important to note that hepatitis B vaccine does not provide protection against other types of viral hepatitis, such as hepatitis A or C."
A measles vaccine is a biological preparation that induces immunity against the measles virus. It contains an attenuated (weakened) strain of the measles virus, which stimulates the immune system to produce antibodies that protect against future infection with the wild-type (disease-causing) virus. Measles vaccines are typically administered in combination with vaccines against mumps and rubella (German measles), forming the MMR vaccine.
The measles vaccine is highly effective, with one or two doses providing immunity in over 95% of people who receive it. It is usually given to children as part of routine childhood immunization programs, with the first dose administered at 12-15 months of age and the second dose at 4-6 years of age.
Measles vaccination has led to a dramatic reduction in the incidence of measles worldwide and is considered one of the greatest public health achievements of the past century. However, despite widespread availability of the vaccine, measles remains a significant cause of morbidity and mortality in some parts of the world, particularly in areas with low vaccination coverage or where access to healthcare is limited.
A Pertussis vaccine is a type of immunization used to protect against pertussis, also known as whooping cough. It contains components that stimulate the immune system to produce antibodies against the bacteria that cause pertussis, Bordetella pertussis. There are two main types of pertussis vaccines: whole-cell pertussis (wP) vaccines and acellular pertussis (aP) vaccines. wP vaccines contain killed whole cells of B. pertussis, while aP vaccines contain specific components of the bacteria, such as pertussis toxin and other antigens. Pertussis vaccines are often combined with diphtheria and tetanus to form combination vaccines, such as DTaP (diphtheria, tetanus, and acellular pertussis) and TdaP (tetanus, diphtheria, and acellular pertussis). These vaccines are typically given to young children as part of their routine immunization schedule.
Haemophilus vaccines are vaccines that are designed to protect against Haemophilus influenzae type b (Hib), a bacterium that can cause serious infections such as meningitis, pneumonia, and epiglottitis. There are two main types of Hib vaccines:
1. Polysaccharide vaccine: This type of vaccine is made from the sugar coating (polysaccharide) of the bacterial cells. It is not effective in children under 2 years of age because their immune systems are not yet mature enough to respond effectively to this type of vaccine.
2. Conjugate vaccine: This type of vaccine combines the polysaccharide with a protein carrier, which helps to stimulate a stronger and more sustained immune response. It is effective in infants as young as 6 weeks old.
Hib vaccines are usually given as part of routine childhood immunizations starting at 2 months of age. They are administered through an injection into the muscle. The vaccine is safe and effective, with few side effects. Vaccination against Hib has led to a significant reduction in the incidence of Hib infections worldwide.
BCG (Bacillus Calmette-Guérin) vaccine is a type of immunization used primarily to prevent tuberculosis (TB). It contains a live but weakened strain of Mycobacterium bovis, which is related to the bacterium that causes TB in humans (Mycobacterium tuberculosis).
The BCG vaccine works by stimulating an immune response in the body, enabling it to better resist infection with TB bacteria if exposed in the future. It is often given to infants and children in countries where TB is common, and its use varies depending on the national immunization policies. The protection offered by the BCG vaccine is moderate and may not last for a very long time.
In addition to its use against TB, the BCG vaccine has also been investigated for its potential therapeutic role in treating bladder cancer and some other types of cancer. The mechanism of action in these cases is thought to be related to the vaccine's ability to stimulate an immune response against abnormal cells.
Poliovirus Vaccine, Inactivated (IPV) is a vaccine used to prevent poliomyelitis (polio), a highly infectious disease caused by the poliovirus. IPV contains inactivated (killed) polioviruses of all three poliovirus types. It works by stimulating an immune response in the body, but because the viruses are inactivated, they cannot cause polio. After vaccination, the immune system recognizes and responds to the inactivated viruses, producing antibodies that protect against future infection with wild, or naturally occurring, polioviruses. IPV is typically given as an injection in the leg or arm, and a series of doses are required for full protection. It is a safe and effective way to prevent polio and its complications.
Rabies vaccines are medical products that contain antigens of the rabies virus, which stimulate an immune response in individuals who receive them. The purpose of rabies vaccines is to prevent the development of rabies, a viral disease that is almost always fatal once symptoms appear.
There are two primary types of rabies vaccines available:
1. Pre-exposure prophylaxis (PrEP) vaccines: These vaccines are given to individuals who are at high risk of coming into contact with the rabies virus, such as veterinarians, animal handlers, and travelers visiting areas where rabies is common. The vaccine series typically consists of three doses given over a period of 28 days.
2. Post-exposure prophylaxis (PEP) vaccines: These vaccines are administered to individuals who have already been exposed to the rabies virus, usually through a bite or scratch from an infected animal. The vaccine series typically consists of four doses given over a period of 14 days, along with a dose of rabies immune globulin (RIG) to provide immediate protection while the immune system responds to the vaccine.
Both types of rabies vaccines are highly effective at preventing the disease, but it is essential to receive them as soon as possible after exposure or before potential exposure, as the virus can be fatal if left untreated.
Rotavirus vaccines are preventive measures used to protect against rotavirus infections, which are the leading cause of severe diarrhea and dehydration among infants and young children worldwide. These vaccines contain weakened or inactivated forms of the rotavirus, a pathogen that infects and causes symptoms by multiplying inside cells lining the small intestine.
The weakened or inactivated virus in the vaccine stimulates an immune response in the body, enabling it to recognize and fight off future rotavirus infections more effectively. The vaccines are usually administered orally, as a liquid droplet or on a sugar cube, to mimic natural infection through the gastrointestinal tract.
There are currently two licensed rotavirus vaccines available globally:
1. Rotarix (GlaxoSmithKline): This vaccine contains an attenuated (weakened) strain of human rotavirus and is given in a two-dose series, typically at 2 and 4 months of age.
2. RotaTeq (Merck): This vaccine contains five reassortant viruses, combining human and animal strains to provide broader protection. It is administered in a three-dose series, usually at 2, 4, and 6 months of age.
Rotavirus vaccines have been shown to significantly reduce the incidence of severe rotavirus gastroenteritis and related hospitalizations among infants and young children. The World Health Organization (WHO) recommends the inclusion of rotavirus vaccination in national immunization programs, particularly in countries with high child mortality rates due to diarrheal diseases.
Capsid proteins are the structural proteins that make up the capsid, which is the protective shell of a virus. The capsid encloses the viral genome and helps to protect it from degradation and detection by the host's immune system. Capsid proteins are typically arranged in a symmetrical pattern and can self-assemble into the capsid structure when exposed to the viral genome.
The specific arrangement and composition of capsid proteins vary between different types of viruses, and they play important roles in the virus's life cycle, including recognition and binding to host cells, entry into the cell, and release of the viral genome into the host cytoplasm. Capsid proteins can also serve as targets for antiviral therapies and vaccines.
Cholera vaccines are preventive measures used to protect against the infection caused by the bacterium Vibrio cholerae. There are several types of cholera vaccines available, including:
1. Inactivated oral vaccine (ICCV): This vaccine contains killed whole-cell bacteria and is given in two doses, with each dose administered at least 14 days apart. It provides protection for up to six months and can be given to adults and children over the age of one year.
2. Live attenuated oral vaccine (LCV): This vaccine contains weakened live bacteria that are unable to cause disease but still stimulate an immune response. The most commonly used LCV is called CVD 103-HgR, which is given in a single dose and provides protection for up to three months. It can be given to adults and children over the age of six years.
3. Injectable cholera vaccine: This vaccine contains inactivated bacteria and is given as an injection. It is not widely available and its effectiveness is limited compared to oral vaccines.
Cholera vaccines are recommended for travelers visiting areas with known cholera outbreaks, particularly if they plan to eat food or drink water that may be contaminated. They can also be used in response to outbreaks to help control the spread of the disease. However, it is important to note that vaccination alone is not sufficient to prevent cholera infection and good hygiene practices, such as handwashing and safe food handling, should always be followed.
Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.
Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.
The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.
In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.
Socioeconomic factors are a range of interconnected conditions and influences that affect the opportunities and resources a person or group has to maintain and improve their health and well-being. These factors include:
1. Economic stability: This includes employment status, job security, income level, and poverty status. Lower income and lack of employment are associated with poorer health outcomes.
2. Education: Higher levels of education are generally associated with better health outcomes. Education can affect a person's ability to access and understand health information, as well as their ability to navigate the healthcare system.
3. Social and community context: This includes factors such as social support networks, discrimination, and community safety. Strong social supports and positive community connections are associated with better health outcomes, while discrimination and lack of safety can negatively impact health.
4. Healthcare access and quality: Access to affordable, high-quality healthcare is an important socioeconomic factor that can significantly impact a person's health. Factors such as insurance status, availability of providers, and cultural competency of healthcare systems can all affect healthcare access and quality.
5. Neighborhood and built environment: The physical conditions in which people live, work, and play can also impact their health. Factors such as housing quality, transportation options, availability of healthy foods, and exposure to environmental hazards can all influence health outcomes.
Socioeconomic factors are often interrelated and can have a cumulative effect on health outcomes. For example, someone who lives in a low-income neighborhood with limited access to healthy foods and safe parks may also face challenges related to employment, education, and healthcare access that further impact their health. Addressing socioeconomic factors is an important part of promoting health equity and reducing health disparities.
Typhoid-Paratyphoid vaccines are immunizations that protect against typhoid fever and paratyphoid fevers, which are caused by the Salmonella enterica serovars Typhi and Paratyphi, respectively. These vaccines contain inactivated or attenuated bacteria or specific antigens that stimulate an individual's immune system to develop immunity against these diseases without causing the illness itself. There are several types of typhoid-paratyphoid vaccines available, including:
1. Ty21a (oral live attenuated vaccine): This is a live but weakened form of the Salmonella Typhi bacteria. It is given orally in capsule form and requires a series of 4 doses taken every other day. The vaccine provides protection for about 5-7 years.
2. Vi polysaccharide (ViPS) typhoid vaccine: This vaccine contains purified Vi antigens from the Salmonella Typhi bacterium's outer capsular layer. It is given as an injection and provides protection for approximately 2-3 years.
3. Combined typhoid-paratyphoid A and B vaccines (Vi-rEPA): This vaccine combines Vi polysaccharide antigens from Salmonella Typhi and Paratyphi A and B. It is given as an injection and provides protection for about 3 years against typhoid fever and paratyphoid fevers A and B.
4. Typhoid conjugate vaccines (TCVs): These vaccines combine the Vi polysaccharide antigen from Salmonella Typhi with a protein carrier to enhance the immune response, particularly in children under 2 years of age. TCVs are given as an injection and provide long-lasting protection against typhoid fever.
It is important to note that none of these vaccines provides 100% protection, but they significantly reduce the risk of contracting typhoid or paratyphoid fevers. Additionally, good hygiene practices, such as handwashing and safe food handling, can further minimize the risk of infection.
The Smallpox vaccine is not a live virus vaccine but is instead made from a vaccinia virus, which is a virus related to the variola virus (the virus that causes smallpox). The vaccinia virus used in the vaccine does not cause smallpox, but it does cause a milder illness with symptoms such as a fever and a rash of pustules or blisters at the site of inoculation.
The smallpox vaccine was first developed by Edward Jenner in 1796 and is one of the oldest vaccines still in use today. It has been highly effective in preventing smallpox, which was once a major cause of death and disability worldwide. In fact, smallpox was declared eradicated by the World Health Organization (WHO) in 1980, thanks in large part to the widespread use of the smallpox vaccine.
Despite the eradication of smallpox, the smallpox vaccine is still used today in certain circumstances. For example, it may be given to laboratory workers who handle the virus or to military personnel who may be at risk of exposure to the virus. The vaccine may also be used as an emergency measure in the event of a bioterrorism attack involving smallpox.
It is important to note that the smallpox vaccine is not without risks and can cause serious side effects, including a severe allergic reaction (anaphylaxis), encephalitis (inflammation of the brain), and myocarditis (inflammation of the heart muscle). As a result, it is only given to people who are at high risk of exposure to the virus and who have been determined to be good candidates for vaccination by a healthcare professional.
A Human Papillomavirus (HPV) DNA test is a molecular diagnostic assay used to detect the presence or absence of DNA from high-risk types of HPV in cervical or anal samples. High-risk HPV types are those most strongly associated with an increased risk for developing cervical cancer and other anogenital cancers.
HPV DNA tests typically use polymerase chain reaction (PCR) or other nucleic acid amplification techniques to detect and quantify the viral DNA in clinical samples. These tests can help identify women at higher risk for cervical precancer or cancer, particularly when combined with cytology results from a Pap test.
HPV DNA testing is recommended as a primary screening method for cervical cancer in certain populations or as a follow-up test to abnormal Pap test results. It's important to note that HPV DNA tests do not diagnose cervical precancer or cancer but rather identify the presence of high-risk HPV types, which may increase the risk of developing these conditions over time.
Immunologic adjuvants are substances that are added to a vaccine to enhance the body's immune response to the antigens contained in the vaccine. They work by stimulating the immune system and promoting the production of antibodies and activating immune cells, such as T-cells and macrophages, which help to provide a stronger and more sustained immune response to the vaccine.
Immunologic adjuvants can be derived from various sources, including bacteria, viruses, and chemicals. Some common examples include aluminum salts (alum), oil-in-water emulsions (such as MF59), and bacterial components (such as lipopolysaccharide or LPS).
The use of immunologic adjuvants in vaccines can help to improve the efficacy of the vaccine, particularly for vaccines that contain weak or poorly immunogenic antigens. They can also help to reduce the amount of antigen needed in a vaccine, which can be beneficial for vaccines that are difficult or expensive to produce.
It's important to note that while adjuvants can enhance the immune response to a vaccine, they can also increase the risk of adverse reactions, such as inflammation and pain at the injection site. Therefore, the use of immunologic adjuvants must be carefully balanced against their potential benefits and risks.
A tuberculosis vaccine, also known as the BCG (Bacillus Calmette-Guérin) vaccine, is a type of immunization used to prevent tuberculosis (TB), a bacterial infection caused by Mycobacterium tuberculosis. The BCG vaccine contains a weakened strain of the bacteria that causes TB in cattle.
The BCG vaccine works by stimulating an immune response in the body, which helps to protect against severe forms of TB, such as TB meningitis and TB in children. However, it is not very effective at preventing pulmonary TB (TB that affects the lungs) in adults.
The BCG vaccine is not routinely recommended for use in the United States due to the low risk of TB infection in the general population. However, it may be given to people who are at high risk of exposure to TB, such as healthcare workers, laboratory personnel, and people traveling to countries with high rates of TB.
It is important to note that the BCG vaccine does not provide complete protection against TB and that other measures, such as testing and treatment for latent TB infection, are also important for controlling the spread of this disease.
Inhalation is the act or process of breathing in where air or other gases are drawn into the lungs. It's also known as inspiration. This process involves several muscles, including the diaphragm and intercostal muscles between the ribs, working together to expand the chest cavity and decrease the pressure within the thorax, which then causes air to flow into the lungs.
In a medical context, inhalation can also refer to the administration of medications or therapeutic gases through the respiratory tract, typically using an inhaler or nebulizer. This route of administration allows for direct delivery of the medication to the lungs, where it can be quickly absorbed into the bloodstream and exert its effects.
Virosomes are artificially constructed spherical vesicles composed of lipids and viral envelope proteins. They are used as a delivery system for vaccines and other therapeutic agents. In the context of vaccines, virosomes can be used to present viral antigens to the immune system in a way that mimics a natural infection, thereby inducing a strong immune response.
Virosome-based vaccines have several advantages over traditional vaccines. For example, they are non-infectious, meaning they do not contain live or attenuated viruses, which makes them safer for certain populations such as immunocompromised individuals. Additionally, virosomes can be engineered to target specific cells in the body, leading to more efficient uptake and presentation of antigens to the immune system.
Virosome-based vaccines have been developed for a variety of diseases, including influenza, hepatitis A, and HIV. While they are not yet widely used, they show promise as a safe and effective alternative to traditional vaccine approaches.
The chickenpox vaccine, also known as varicella vaccine, is a preventive measure against the highly contagious viral infection caused by the varicella-zoster virus. The vaccine contains a live but weakened form of the virus, which stimulates the immune system to produce a response without causing the disease itself.
The chickenpox vaccine is typically given in two doses, with the first dose administered between 12 and 15 months of age and the second dose between 4 and 6 years of age. In some cases, the vaccine may be given to older children, adolescents, or adults who have not previously been vaccinated or who have never had chickenpox.
The chickenpox vaccine is highly effective at preventing severe cases of the disease and reducing the risk of complications such as bacterial infections, pneumonia, and encephalitis. It is also effective at preventing transmission of the virus to others.
Like any vaccine, the chickenpox vaccine can cause mild side effects such as soreness at the injection site, fever, or a mild rash. However, these side effects are generally mild and short-lived. Serious side effects are rare but may include allergic reactions or severe immune responses.
Overall, the chickenpox vaccine is a safe and effective way to prevent this common childhood disease and its potential complications.
The Diphtheria-Tetanus-Pertussis (DTaP) vaccine is a combination immunization that protects against three bacterial diseases: diphtheria, tetanus (lockjaw), and pertussis (whooping cough).
Diphtheria is an upper respiratory infection that can lead to breathing difficulties, heart failure, paralysis, or even death. Tetanus is a bacterial infection that affects the nervous system and causes muscle stiffness and spasms, leading to "lockjaw." Pertussis is a highly contagious respiratory infection characterized by severe coughing fits, which can make it difficult to breathe and may lead to pneumonia, seizures, or brain damage.
The DTaP vaccine contains inactivated toxins (toxoids) from the bacteria that cause these diseases. It is typically given as a series of five shots, with doses administered at 2 months, 4 months, 6 months, 15-18 months, and 4-6 years of age. The vaccine helps the immune system develop protection against the diseases without causing the actual illness.
It is important to note that there are other combination vaccines available that protect against these same diseases, such as DT (diphtheria and tetanus toxoids) and Tdap (tetanus, diphtheria, and acellular pertussis), which contain higher doses of the diphtheria and pertussis components. These vaccines are recommended for different age groups and may be used as booster shots to maintain immunity throughout adulthood.
Keratinocytes are the predominant type of cells found in the epidermis, which is the outermost layer of the skin. These cells are responsible for producing keratin, a tough protein that provides structural support and protection to the skin. Keratinocytes undergo constant turnover, with new cells produced in the basal layer of the epidermis and older cells moving upward and eventually becoming flattened and filled with keratin as they reach the surface of the skin, where they are then shed. They also play a role in the immune response and can release cytokines and other signaling molecules to help protect the body from infection and injury.
Penile neoplasms refer to abnormal growths or tumors in the penis. These can be benign (non-cancerous) or malignant (cancerous). The most common type of penile cancer is squamous cell carcinoma, which begins in the flat cells that line the surface of the penis. Other types of penile cancer include melanoma, basal cell carcinoma, and adenocarcinoma.
Benign penile neoplasms include conditions such as papillomas, condylomas, and peyronie's disease. These growths are usually not life-threatening, but they can cause discomfort, pain, or other symptoms that may require medical treatment.
It is important to note that any unusual changes in the penis, such as lumps, bumps, or sores, should be evaluated by a healthcare professional to determine the underlying cause and appropriate treatment.
Vulvar neoplasms refer to abnormal growths or tumors in the vulvar region, which is the exterior female genital area including the mons pubis, labia majora, labia minora, clitoris, and the vaginal vestibule. These neoplasms can be benign (non-cancerous) or malignant (cancerous).
Benign vulvar neoplasms may include conditions such as vulvar cysts, fibromas, lipomas, or condylomas (genital warts). They are typically slow-growing and less likely to spread or invade surrounding tissues.
Malignant vulvar neoplasms, on the other hand, are cancers that can invade nearby tissues and potentially metastasize (spread) to distant parts of the body. The most common types of malignant vulvar neoplasms are squamous cell carcinoma, vulvar melanoma, and adenocarcinoma.
Early detection and treatment of vulvar neoplasms are essential for improving prognosis and reducing the risk of complications or recurrence. Regular gynecological examinations, self-examinations, and prompt attention to any unusual symptoms or changes in the vulvar area can help ensure timely diagnosis and management.
Antipyrine is a chemical compound that was commonly used as a fever reducer and pain reliever in the past. It is a type of phenylpyrazole antipyretic and analgesic. However, due to its potential for causing liver damage and other side effects, it has largely been replaced by other medications and is not widely used in modern medicine.
The medical definition of Antipyrine refers to this specific chemical compound with the formula C11H13N3O2, and not to any broader category of drugs or substances. It is a white crystalline powder that is soluble in alcohol, chloroform, and ether, but insoluble in water.
Antipyrine was first synthesized in 1883 and was widely used as a fever reducer and pain reliever until the mid-20th century. However, its use declined due to concerns about its safety profile, including the potential for liver damage, skin reactions, and other side effects.
Today, Antipyrine is still used in some medical applications, such as in the measurement of earwax conductivity as a way to assess hearing function. It may also be used in some topical creams and ointments for pain relief. However, its use as a systemic medication is generally not recommended due to its potential for causing harm.
The Mumps Vaccine is a biological preparation intended to induce immunity against mumps, a contagious viral infection that primarily affects the salivary glands. The vaccine contains live attenuated (weakened) mumps virus, which stimulates the immune system to develop a protective response without causing the disease.
There are two types of mumps vaccines available:
1. The Jeryl Lynn strain is used in the United States and is part of the Measles, Mumps, and Rubella (MMR) vaccine and the Measles, Mumps, Rubella, and Varicella (MMRV) vaccine. This strain is derived from a clinical isolate obtained from the throat washings of a child with mumps in 1963.
2. The Urabe AM9 strain was used in some countries but has been discontinued in many places due to an increased risk of meningitis as a rare complication.
The MMR vaccine is typically given to children at 12-15 months of age and again at 4-6 years of age, providing long-lasting immunity against mumps in most individuals. The vaccine has significantly reduced the incidence of mumps and its complications worldwide.
Repressor proteins are a type of regulatory protein in molecular biology that suppress the transcription of specific genes into messenger RNA (mRNA) by binding to DNA. They function as part of gene regulation processes, often working in conjunction with an operator region and a promoter region within the DNA molecule. Repressor proteins can be activated or deactivated by various signals, allowing for precise control over gene expression in response to changing cellular conditions.
There are two main types of repressor proteins:
1. DNA-binding repressors: These directly bind to specific DNA sequences (operator regions) near the target gene and prevent RNA polymerase from transcribing the gene into mRNA.
2. Allosteric repressors: These bind to effector molecules, which then cause a conformational change in the repressor protein, enabling it to bind to DNA and inhibit transcription.
Repressor proteins play crucial roles in various biological processes, such as development, metabolism, and stress response, by controlling gene expression patterns in cells.
Secondary immunization, also known as "anamnestic response" or "booster," refers to the enhanced immune response that occurs upon re-exposure to an antigen, having previously been immunized or infected with the same pathogen. This response is characterized by a more rapid and robust production of antibodies and memory cells compared to the primary immune response. The secondary immunization aims to maintain long-term immunity against infectious diseases and improve vaccine effectiveness. It usually involves administering additional doses of a vaccine or booster shots after the initial series of immunizations, which helps reinforce the immune system's ability to recognize and combat specific pathogens.
Viral proteins are the proteins that are encoded by the viral genome and are essential for the viral life cycle. These proteins can be structural or non-structural and play various roles in the virus's replication, infection, and assembly process. Structural proteins make up the physical structure of the virus, including the capsid (the protein shell that surrounds the viral genome) and any envelope proteins (that may be present on enveloped viruses). Non-structural proteins are involved in the replication of the viral genome and modulation of the host cell environment to favor viral replication. Overall, a thorough understanding of viral proteins is crucial for developing antiviral therapies and vaccines.
Hepatitis A vaccines are inactivated or live attenuated viral vaccines that are administered to prevent infection and illness caused by the hepatitis A virus. The vaccine contains antigens that stimulate an immune response in the body, leading to the production of antibodies that protect against future infection with the virus.
The inactivated hepatitis A vaccine is made from viruses that have been chemically treated to destroy their ability to cause disease while preserving their ability to stimulate an immune response. This type of vaccine is typically given in two doses, six months apart, and provides long-term protection against the virus.
The live attenuated hepatitis A vaccine contains a weakened form of the virus that is unable to cause illness but can still stimulate an immune response. This type of vaccine is given as a single dose and provides protection against the virus for at least 20 years.
Hepatitis A vaccines are recommended for people who are at increased risk of infection, including travelers to areas where hepatitis A is common, men who have sex with men, people who use injection drugs, and people with chronic liver disease or clotting factor disorders. The vaccine is also recommended for children in certain states and communities where hepatitis A is endemic.
Immunization is defined medically as the process where an individual is made immune or resistant to an infectious disease, typically through the administration of a vaccine. The vaccine stimulates the body's own immune system to recognize and fight off the specific disease-causing organism, thereby preventing or reducing the severity of future infections with that organism.
Immunization can be achieved actively, where the person is given a vaccine to trigger an immune response, or passively, where antibodies are transferred to the person through immunoglobulin therapy. Immunizations are an important part of preventive healthcare and have been successful in controlling and eliminating many infectious diseases worldwide.
Cell transformation, viral refers to the process by which a virus causes normal cells to become cancerous or tumorigenic. This occurs when the genetic material of the virus integrates into the DNA of the host cell and alters its regulation, leading to uncontrolled cell growth and division. Some viruses known to cause cell transformation include human papillomavirus (HPV), hepatitis B virus (HBV), and certain types of herpesviruses.
A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.
The Measles-Mumps-Rubella (MMR) vaccine is a combination immunization that protects against three infectious diseases: measles, mumps, and rubella. It contains live attenuated viruses of each disease, which stimulate an immune response in the body similar to that produced by natural infection but do not cause the diseases themselves.
The MMR vaccine is typically given in two doses, the first at 12-15 months of age and the second at 4-6 years of age. It is highly effective in preventing these diseases, with over 90% effectiveness reported after a single dose and near 100% effectiveness after the second dose.
Measles is a highly contagious viral disease that can cause fever, rash, cough, runny nose, and red, watery eyes. It can also lead to serious complications such as pneumonia, encephalitis (inflammation of the brain), and even death.
Mumps is a viral infection that primarily affects the salivary glands, causing swelling and tenderness in the cheeks and jaw. It can also cause fever, headache, muscle aches, and fatigue. Mumps can lead to serious complications such as deafness, meningitis (inflammation of the membranes surrounding the brain and spinal cord), and inflammation of the testicles or ovaries.
Rubella, also known as German measles, is a viral infection that typically causes a mild fever, rash, and swollen lymph nodes. However, if a pregnant woman becomes infected with rubella, it can cause serious birth defects such as hearing impairment, heart defects, and developmental delays in the fetus.
The MMR vaccine is an important tool in preventing these diseases and protecting public health.
Squamous cell carcinoma is a type of skin cancer that begins in the squamous cells, which are flat, thin cells that form the outer layer of the skin (epidermis). It commonly occurs on sun-exposed areas such as the face, ears, lips, and backs of the hands. Squamous cell carcinoma can also develop in other areas of the body including the mouth, lungs, and cervix.
This type of cancer usually develops slowly and may appear as a rough or scaly patch of skin, a red, firm nodule, or a sore or ulcer that doesn't heal. While squamous cell carcinoma is not as aggressive as some other types of cancer, it can metastasize (spread) to other parts of the body if left untreated, making early detection and treatment important.
Risk factors for developing squamous cell carcinoma include prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds, fair skin, a history of sunburns, a weakened immune system, and older age. Prevention measures include protecting your skin from the sun by wearing protective clothing, using a broad-spectrum sunscreen with an SPF of at least 30, avoiding tanning beds, and getting regular skin examinations.
Streptococcal vaccines are immunizations designed to protect against infections caused by Streptococcus bacteria. These vaccines contain antigens, which are substances that trigger an immune response and help the body recognize and fight off specific types of Streptococcus bacteria. There are several different types of streptococcal vaccines available or in development, including:
1. Pneumococcal conjugate vaccine (PCV): This vaccine protects against Streptococcus pneumoniae, a type of bacteria that can cause pneumonia, meningitis, and other serious infections. PCV is recommended for all children under 2 years old, as well as older children and adults with certain medical conditions.
2. Pneumococcal polysaccharide vaccine (PPSV): This vaccine also protects against Streptococcus pneumoniae, but it is recommended for adults 65 and older, as well as younger people with certain medical conditions.
3. Streptococcus pyogenes vaccine: This vaccine is being developed to protect against Group A Streptococcus (GAS), which can cause a variety of infections, including strep throat, skin infections, and serious diseases like rheumatic fever and toxic shock syndrome. There are several different GAS vaccine candidates in various stages of development.
4. Streptococcus agalactiae vaccine: This vaccine is being developed to protect against Group B Streptococcus (GBS), which can cause serious infections in newborns, pregnant women, and older adults with certain medical conditions. There are several different GBS vaccine candidates in various stages of development.
Overall, streptococcal vaccines play an important role in preventing bacterial infections and reducing the burden of disease caused by Streptococcus bacteria.
Anthrax vaccines are biological preparations designed to protect against anthrax, a potentially fatal infectious disease caused by the bacterium Bacillus anthracis. Anthrax can affect both humans and animals, and it is primarily transmitted through contact with contaminated animal products or, less commonly, through inhalation of spores.
There are two types of anthrax vaccines currently available:
1. Anthrax Vaccine Adsorbed (AVA): This vaccine is licensed for use in the United States and is approved for pre-exposure prophylaxis in high-risk individuals, such as military personnel and laboratory workers who handle the bacterium. AVA contains a cell-free filtrate of cultured B. anthracis cells that have been chemically treated to render them non-infectious. The vaccine works by stimulating the production of antibodies against protective antigens (PA) present in the bacterial culture.
2. Recombinant Anthrax Vaccine (rPA): This vaccine, also known as BioThrax, is a newer generation anthrax vaccine that was approved for use in the United States in 2015. It contains only the recombinant protective antigen (rPA) of B. anthracis, which is produced using genetic engineering techniques. The rPA vaccine has been shown to be as effective as AVA in generating an immune response and offers several advantages, including a more straightforward manufacturing process, fewer side effects, and a longer shelf life.
Both vaccines require multiple doses for initial immunization, followed by periodic booster shots to maintain protection. Anthrax vaccines are generally safe and effective at preventing anthrax infection; however, they may cause mild to moderate side effects, such as soreness at the injection site, fatigue, and muscle aches. Severe allergic reactions are rare but possible.
It is important to note that anthrax vaccines do not provide immediate protection against anthrax infection. They require several weeks to stimulate an immune response, so they should be administered before potential exposure to the bacterium. In cases of known or suspected exposure to anthrax, antibiotics are used as a primary means of preventing and treating the disease.
Gene expression regulation, viral, refers to the processes that control the production of viral gene products, such as proteins and nucleic acids, during the viral life cycle. This can involve both viral and host cell factors that regulate transcription, RNA processing, translation, and post-translational modifications of viral genes.
Viral gene expression regulation is critical for the virus to replicate and produce progeny virions. Different types of viruses have evolved diverse mechanisms to regulate their gene expression, including the use of promoters, enhancers, transcription factors, RNA silencing, and epigenetic modifications. Understanding these regulatory processes can provide insights into viral pathogenesis and help in the development of antiviral therapies.
Dengue vaccines are designed to protect against dengue fever, a mosquito-borne viral disease that can cause severe flu-like symptoms and potentially life-threatening complications. Dengue is caused by four distinct serotypes of the virus (DENV-1, DENV-2, DENV-3, and DENV-4), and infection with one serotype does not provide immunity against the others.
The first licensed dengue vaccine, Dengvaxia (CYD-TDV), is a chimeric yellow fever-dengue tetravalent vaccine developed by Sanofi Pasteur. It is approved for use in several countries and has demonstrated efficacy against dengue fever caused by all four serotypes in clinical trials. However, the vaccine has raised concerns about the risk of severe disease in individuals who have not been previously exposed to dengue. As a result, it is recommended primarily for people with a documented past dengue infection or living in areas with high dengue prevalence and where the benefits outweigh the risks.
Another dengue vaccine candidate, Takeda's TAK-003 (also known as TDV), is a live attenuated tetravalent dengue vaccine that has shown efficacy against all four serotypes in clinical trials. It was granted approval by the European Medicines Agency (EMA) and several other countries for use in individuals aged 4-16 years old, living in endemic areas.
Research and development of additional dengue vaccine candidates are ongoing to address concerns about safety, efficacy, and accessibility, particularly for at-risk populations in low- and middle-income countries where dengue is most prevalent.
Oropharyngeal neoplasms refer to abnormal growths or tumors in the oropharynx, which is the middle part of the pharynx (throat) that includes the back one-third of the tongue, the soft palate, the side and back walls of the throat, and the tonsils. These neoplasms can be benign (non-cancerous) or malignant (cancerous). Oropharyngeal cancer is a significant global health concern, with squamous cell carcinoma being the most common type of malignant neoplasm in this region. The primary risk factors for oropharyngeal cancers include tobacco use, alcohol consumption, and human papillomavirus (HPV) infection. Early detection and treatment are crucial for improving outcomes and survival rates.
Gamma-papillomaviruses, also known as Gammapapillomavirus (γPV), are a genus of papillomaviruses that primarily infect the epithelial cells of birds and some non-human mammals. They have not been definitively associated with any human diseases.
Gamma-papillomaviruses are characterized by their double-stranded DNA genome, which encodes several proteins involved in the virus's replication and regulation. The two main types of proteins encoded by these viruses are early proteins, which are expressed before viral DNA replication, and late proteins, which are expressed after viral DNA replication.
These viruses can cause benign growths called papillomas or warts in their hosts. However, some gamma-papillomaviruses have been associated with the development of cancerous lesions in animals, particularly in birds. It's important to note that while gamma-papillomaviruses have not been definitively linked to human cancers, other types of papillomaviruses are known to cause various types of human cancers, including cervical, anal, and oropharyngeal cancers.
Colposcopy is a medical procedure in which a colposcope, which is a type of microscope, is used to examine the cervix, vagina, and vulva for signs of disease or abnormalities. The colposcope allows the healthcare provider to see these areas in greater detail than is possible with the naked eye. During the procedure, the provider may take a small sample of tissue (biopsy) for further examination under a microscope.
Colposcopy is often used to investigate abnormal Pap test results or to follow up on women who have been diagnosed with certain types of cervical dysplasia (abnormal cell growth). It can also be used to diagnose and monitor other conditions, such as genital warts, inflammation, or cancer.
It is important to note that colposcopy is a diagnostic procedure and not a treatment. If abnormalities are found during the exam, additional procedures may be necessary to remove or treat them.
Virus-like particles (VLPs) are nanostructures that mimic the organization and conformation of authentic viruses but lack the genetic material required for replication. VLPs can be produced from one or more viral proteins, which can be derived from various expression systems including bacteria, yeast, insect, or mammalian cells.
VLP-based vaccines are a type of vaccine that uses these virus-like particles to induce an immune response in the body. These vaccines can be designed to target specific viruses or other pathogens and have been shown to be safe and effective in inducing both humoral and cellular immunity.
VLPs resemble authentic viruses in their structure, size, and antigenic properties, making them highly immunogenic. They can be designed to present specific epitopes or antigens from a pathogen, which can stimulate the immune system to produce antibodies and activate T-cells that recognize and attack the pathogen.
VLP vaccines have been developed for several viruses, including human papillomavirus (HPV), hepatitis B virus (HBV), and respiratory syncytial virus (RSV). They offer several advantages over traditional vaccines, such as a strong immune response, safety, and stability.
Vaccine
Bovine papillomavirus
Cervical cancer
Jian Zhou
Wart
Cervix
Gardasil
Cervical intraepithelial neoplasia
HPV vaccine
Cervarix
IP Australia
Glossary of medicine
Xiamen Innovax Biotech
Saveria Campo
Subunit vaccine
List of sexually transmitted infections by prevalence
Human Papillomavirus (HPV) in Ghana
Riko Muranaka
Yellow fever
Monica McLemore
Bradley J. Monk
Cervical Cancer Gene Database
Karen Canfell
HspE7
Retinoblastoma protein
Franco Borruto
Neal Halsey
Anal cancer
Anna-Lise Williamson
Cancer
Human Papillomavirus (HPV) Vaccine : MedlinePlus Drug Information
HPV Vaccine | Human Papillomavirus (HPV) | CDC
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine
Human Papillomavirus (HPV) Medication: Immunomodulators, Keratolytic Agents, Antineoplastics, Antimetabolite, Topical Skin...
Vaccines | Free Full-Text | Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
Efficacy and other milestones for human papillomavirus vaccine introduction
Your Child's Immunizations: Human Papillomavirus (HPV) Vaccine (for Parents) - Johns Hopkins All Children's Hospital
Infographics - Human Papillomavirus (HPV) Vaccines Market
HPV Vaccine (Human Papillomavirus Vaccine) - Samoan version - HealthEd
Human Papillomavirus (HPV) Vaccine
Could The Human Papillomavirus Vaccines Drive Virulence Evolution?
Human Papillomavirus (HPV) Vaccine - Brant County Health Unit
Interim VIS for Human Papillomavirus vaccine | Migrant Clinicians Network
Ampiginous choroiditis following quadrivalent human papilloma virus vaccine | British Journal of Ophthalmology
Quadrivalent human papillomavirus vaccine (Gardasil) available for boys - NPS MedicineWise
Human Papillomavirus (HPV) vaccines session
Human Papillomavirus (HPV) Vaccine - Infections - MSD Manual Consumer Version
QuickStats: Percentage of Adults Aged 18-26 Years Who Ever Received a Human Papillomavirus Vaccine, by Race and Hispanic Origin...
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus...
WHO EMRO | Acceptability of the human papilloma virus vaccine among Moroccan parents: a population-based cross-sectional study ...
Vaccines for human papilloma virus and methods for using the same - Patent EP-2750703-B1 - PubChem
O027 Rapid fall in quadrivalent vaccine targeted human papillomavirus genotypes in heterosexual men following the Australian...
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease:...
Human Papillomavirus (HPV) Vaccine - Infections - MSD Manual Consumer Version
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer...
Using the theory of planned behavior to assess factors that influence the intent to use human papillomavirus (HPV) vaccine...
Human Papilloma Virus (HPV) Vaccine Offered to Boys Beginning This Fall - Saskatchewan Party Caucus
Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices ...
Gardasil5
- The HPV 9-valent (Gardasil 9) is the only HPV vaccine available in the United States. (medscape.com)
- The HPV 2-valent vaccine (Cervarix), which covered types 16 and 18, and the HPV 4-valent vaccine (Gardasil), which covered types 6, 11, 16, and 18, were discontinued in the United States in October 2016. (medscape.com)
- The vaccine currently used to protect against HPV is called Gardasil 9. (thevaccinemom.com)
- Gardasil vaccine age range, Plasturi talpi detoxifiere pareri duct papilloma of breast icd 10, papillomavirus est il contagieux oxiuros en ingles. (granturieuropene.ro)
- The vaccine that is part of this comprehensive immunization is Gardasil 9, which has been approved worldwide by oncologists and plays a significant role in preventing cervical cancer, besides vaginal and vulvar cancer. (pulsexpertech.com)
Infections11
- Some adults ages 27 through 45 years who were not already vaccinated might choose to get HPV vaccine after speaking with their doctor about their risk for new HPV infections and possible benefits of vaccination for them. (cdc.gov)
- HPV infections and cervical precancers (abnormal cells on the cervix that can lead to cancer) have dropped since 2006, when HPV vaccines were first used in the United States. (cdc.gov)
- The medications used to treat human papillomavirus (HPV) infections are primarily designed to ablate the lesion by virtue of their corrosive properties. (medscape.com)
- Indeed, if vaccines prove to be effective against transient or persistent HPV infections, it is likely that they will protect women against cervical cancer. (nih.gov)
- The human papillomavirus (HPV) vaccines hold great promise for preventing several cancers caused by HPV infections. (uwaterloo.ca)
- Comprehensive human papillomavirus vaccine monograph of human papillomavirus infections and related diseases. (adventube.ro)
- Around 70,000 women die of it each year, and around 70% of these cases are caused by infections from HPV strains, which the vaccines prevent. (nammakpsc.com)
- Many adolescents, adults and healthcare providers have a limited understanding of human papillomavirus (HPV) infections, particularly those that are sexually transmitted. (immunizationinfo.org)
- This section explains what HPVs are, how the genital types are acquired, what happens once someone is infected, and discusses strategies for the prevention of genital HPV infections, including strategies for using the new vaccines. (immunizationinfo.org)
- A potential tool for preventing HPV infections and thus cervical and anogenital cancers are vaccines. (immunizationinfo.org)
- The World Health Organization (WHO) reports that licensed vaccines are currently available for twenty-five different preventable infections. (wikipedia.org)
Infection26
- HPV (human papillomavirus) vaccine can prevent get the first dose at or after 15 years of age and infection with some types of human papillomavirus. (cdc.gov)
- HPV (human papillomavirus) vaccine can prevent infection with some types of human papillomavirus. (medlineplus.gov)
- Human papillomavirus (HPV) infection, usually a sexually exist to eliminate HPV infection, precancerous lesions and transmitted disease, is a risk factor for cervical cancer. (cdc.gov)
- A vaccine with a 75% probability of immunity against high-risk HPV infection resulted in a life- results are encouraging (9,10). (cdc.gov)
- The current HPV vaccine recommendations apply to 9 years old and above through the age of 26 years and adults aged 27-45 years who might be at risk of new HPV infection and benefit from vaccination. (mdpi.com)
- Since persistent infection with the same high-risk type is considered a predictor for moderate or high-grade cervical dysplasias and cancer, they might represent a useful endpoint in future vaccine efficacy studies. (nih.gov)
- Get the facts about the HPV vaccine and how it can protect your child from this infection - and some types of cancer - for years to come. (kidshealth.org)
- The vaccine is an important way to prevent infection and the spread of HPV. (kidshealth.org)
- HPV vaccines help to prevent infection by certain strains (e.g. types 16 and 18) of the Human Papillomavirus (HPV), which may lead to cervical cancer in women. (singhealth.com.sg)
- Some people may be at higher risk of HPV infection and eligible for free vaccine. (bchu.org)
- It is important to note that older boys who are sexually active may have already been exposed to various HPV types, including HPV 6, 11, 16 and 18, and that immunisation with the 4vHPV vaccine will not afford protection against pre-existing HPV infection with any of these types. (nps.org.au)
- Human Papillomavirus (HPV) Infection Human papillomavirus (HPV) can be sexually transmitted and causes changes in cells, which can lead to genital warts or to precancer or cancer of the cervix, vagina, vulva, anus, or throat. (msdmanuals.com)
- The vaccine does not contain any live virus and thus cannot cause HPV infection. (msdmanuals.com)
- Despite weak knowledge of genital warts and HPV infection, acceptability of the HPV vaccine was 76.8% (95% CI: 73.3-79.9%) among mothers and 68.9% (95% CI: 65.2-72.5%) among fathers. (who.int)
- Novel laboratory mouse papillomavirus (MusPV) infection. (nature.com)
- Hepatitis B is a vaccine-preventable liver infection caused by the hepatitis B virus (HBV). (safeway.com)
- Human papillomavirus (HPV) is the most common sexually transmitted infection (STI). (nammakpsc.com)
- Human papillomavirus infection and immunization strategies What is human papilloma virus vaccine, Safety of human papillomavirus vaccine - Vaccin HPV - Wikipedia Infectia cu HPV Human Papilloma Virus Vă human papillomavirus vaccine hpv injection urmatoarele stiri human papillomavirus vaccine hpv injection aceeasi categorie Alte traduceri Fortunately, cervical cancer among human papillomavirus vaccine hpv injection injection human papillomavirus vaccine now injection human papillomavirus vaccine prevented with a vaccine HPV. (metin2kiss.ro)
- Expunerea la papilomavirusul uman PVU Cervarix does not protect people from diseases caused by infection with Giardiaza trebuie tratată e types 16 or 18 if they are already infected with Human Papillomavirus type 16 or 18 at the time of vaccination. (metin2kiss.ro)
- Plantar wartsare caused by a viral infection with the what is human papilloma virus vaccine papillomavirus HPV in the outer layer of skin on the soles of the feet. (metin2kiss.ro)
- However, if you already have an HPV infection, the vaccine will not cure it. (pulsexpertech.com)
- Vaccines can be prophylactic (to prevent or alleviate the effects of a future infection by a natural or "wild" pathogen), or therapeutic (to fight a disease that has already occurred, such as cancer). (wikipedia.org)
- Some vaccines offer full sterilizing immunity, in which infection is prevented completely. (wikipedia.org)
- In some cases vaccines may result in partial immune protection (in which immunity is less than 100% effective but still reduces risk of infection) or in temporary immune protection (in which immunity wanes over time) rather than full or permanent immunity. (wikipedia.org)
- Reviewed By Experts Human Papillomavirus infection is a common sexually transmitted infection and serves as the primary catalyst for various epithelial lesions and cancers. (blogarama.com)
- Gregory Poland discusses HPV vaccine for young people papilloma on bladder Papillomavirus infection rate hpv and mouth ulcers, is intraductal papilloma breast cancer cancer gastric her2. (terapiesicoaching.ro)
Types 16 and 184
- All three HPV vaccines protect against the two types of HPV (types 16 and 18) that cause about 70% of cervical cancers and 90% of anal cancers. (msdmanuals.com)
- The nine-valent and quadrivalent vaccines protect against the two types of HPV (types 6 and 11) that cause more than 90% of genital warts, in addition to protecting against types 16 and 18. (msdmanuals.com)
- One of these is Cervarix TM , an AS04-adjuvanted bivalent vaccine against HPV types 16 and 18 produced by GlaxoSmithKline. (biomedcentral.com)
- But with increasing HPV vaccine uptake and decreasing prevalence of high-risk HPV types 16 and 18, HPV testing is expected to lead to far fewer false positives than Pap testing. (medscape.com)
Squamous cell carc2
- De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systema-tic review and meta-analysis of current clinical trials. (adventube.ro)
- Hpv virus vaccine age limit Hpv human papillomavirus age HPV vaccination: Risk factors, sexual history shouldn't guide decisions about it sucuri fresh detoxifiere In addition to tobacco and alcohol abuse, certain viruses have been associated with squamous cell carcinoma SCC of the head and neck, causing alterations in DNA. (granturieuropene.ro)
Cervarix2
- The purpose of this study was to assess the cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine (Cervarix TM ) at age 12 to the current national cervical screening program. (biomedcentral.com)
- Cervarix nu protejează persoanele de boala determinată de infecţia cu HPV 16 sau 18 dacă acestea sunt deja infectate human papillomavirus vaccine cause papilomavirusul uman de tip 16 sau 18 la momentul vaccinării. (metin2kiss.ro)
Vaccination against human papillomavirus4
- Web-only information in Sāmoan about vaccination against human papillomavirus (HPV). (healthed.govt.nz)
- Vaccination against Human Papillomavirus starts in November IPN When treating cervical cancerHycamtin is combined with another medicine, called cisplatin. (granturieuropene.ro)
- Vaccination against Human Papillomavirus starts in November It has been demonstrated that the human papillomavirus age papil-loma-virus HPV type 16, a subtype of the human pa-pil-loma-virus, is present in the oropharyngeal carcinomas of non-smokers patients inclusive. (granturieuropene.ro)
- Neagră plantară imensă Familial cancer clinic westmead hospital Medicamente pentru tratarea viermilor la copii Vaccination against Human Papillomavirus starts in November, Papillomavirus vaccine age Medicamente pentru tenă la oameni Human papillomavirus facts papilloma virus definition, parazitoza copii papiloma y cancer. (granturieuropene.ro)
Prevention3
- Contact the Centers for Disease Control and Prevention (CDC): call 1-800-232-4636 (1-800-CDC-INFO) or visit CDC's website at http://www.cdc.gov/vaccines . (medlineplus.gov)
- The consultation recognized that in the context of many developing countries, efficacy alone might not provide enough information for countries to decide whether or not to adopt HPV vaccines as a public health prevention tool against cervical cancer. (nih.gov)
- Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study. (bvsalud.org)
Cancer52
- HPV vaccine may be given at the same time as penile cancer in men other vaccines. (cdc.gov)
- Epidemiologic research strongly implicates Human papillomavirus (HPV) as the major risk factor for cervical cancer. (cdc.gov)
- Each month, women are at risk of developing Human papillomavirus (HPV) vical cancer also have been infected with HPV (1-7). (cdc.gov)
- After hearing from experts about virological and clinical endpoints to be considered, requirements of regulatory authorities of various countries and endpoints used to measure efficacy and effectiveness for another known cancer vaccine (hepatitis B), the experts agreed that ethical and time considerations make it necessary to use a surrogate endpoint, and not invasive cervical cancer, to define efficacy of HPV vaccines. (nih.gov)
- Recognizing that upon vaccine introduction it will be some years before a reduction in cervical cancer is detectable at the population level, the consultation stressed the importance of maintaining existing cervical screening programmes while such long-term studies are conducted. (nih.gov)
- Human papillomavirus (HPV) is a virus that can cause cervical cancer as well as genital warts. (kidshealth.org)
- The aim of this study was to assess the cost-effectiveness of adding vaccination with the human papillomavirus 16/18 vaccine to the current cervical cancer screening program in Hungary. (biomedcentral.com)
- Our modeling analysis showed that the vaccination of 12-year-old adolescent girls against cervical cancer with the AS04-adjuvanted human papillomavirus 16/18 vaccine would be a cost-effective strategy to prevent cervical cancer in Hungary. (biomedcentral.com)
- Since the introduction of human papillomavirus (HPV) vaccines, both primary and secondary preventive (i.e., screening) measures have been available to prevent cervical cancer. (biomedcentral.com)
- There are two vaccines available for preventing cervical cancer. (biomedcentral.com)
- Doctor: So, HPV stands for human papilloma virus, and this is a virus that can be transmitted sexually and can cause different types of genital warts as well as cancer, but the vaccine can actually prevent the transmission of that virus. (gallaudet.edu)
- Cervical Cancer can be significantly reduced with the Human papillomavirus (HPV) vaccine and appropriate Pap smear screenings to collect cells from your cervix for testing. (whmcenter.com)
- Here we show that T cell immunity against commensal papillomaviruses suppresses skin cancer in immunocompetent hosts, and the loss of this immunity-rather than the oncogenic effect of HPVs-causes the markedly increased risk of skin cancer in immunosuppressed patients. (nature.com)
- To investigate the effects of papillomavirus on carcinogen-driven skin cancer, we colonized several strains of immunocompetent mice with mouse papillomavirus type 1 (MmuPV1) 5 . (nature.com)
- Howley, P. M. & Pfister, H. J. Beta genus papillomaviruses and skin cancer. (nature.com)
- Virol J. Human papillomavirus prevalence in invasive laryngeal cancer in the United States. (adventube.ro)
- Time trends in human papillomavirus vaccine monograph prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. (adventube.ro)
- India has the largest burden of cervical cancer in the world where Human papillomavirus is responsible for 70% of the cases. (nammakpsc.com)
- The human papillomavirus (HPV) vaccine is designed to prevent HPV-related cervical cancer. (nammakpsc.com)
- A vaccine that prevents the HPV strains most likely to cause genital warts and cervical cancer is recommended for boys and girls. (nammakpsc.com)
- The cause of cervical cancer is the human papillomavirus HPV. (metin2kiss.ro)
- Papilloma virus sintomi maschili Traducere "cervical cancer" în română, Injection human papillomavirus vaccine Safety of human papillomavirus human papillomavirus vaccine hpv injection Conținutul Chloe Safety of human papillomavirus vaccine, from Glasgow, was a bubbly and healthy year-old, who had always dreamed of becoming an actress. (metin2kiss.ro)
- Human papillomavirus vaccine effects HPV Vaccine Risks papillomas lumps Tratament prin viermi cancer limfatic simptome cauze, papilloma vescicale g3 helmintii la copii. (mediafilmcenter.ro)
- Cel mai frecvent tip de cancer care este asociat cu infectia Papillomavirus vaccine papillomavirus vaccine risks este cancerul de col uterin. (mediafilmcenter.ro)
- Printre semnele generale papillomavirus vaccine risks se asociaza unui cancer se numara: scaderea in greutate, edematierea umflarea ganglionilor limfatici care pot fi palpati, oboseala. (mediafilmcenter.ro)
- Pentru ca neoplasmul de col uterin este o afectiune frecvent intalnita pentru care exista posibilitatea de a detecta leziunile inainte de transformarea lor in cancer leziuni precanceroase se recomanda efectuarea papillomavirus vaccine risks de screening Babes-Papanicolau. (mediafilmcenter.ro)
- Testul Babes-Papanicolau Pentru efectuarea testului Babes Papanicolau se recolteaza de catre medicul ginecolog secretia prelevata de la nivelul papillomavirus vaccine risks uterin care contine mostre de celule din colul uterin care va fi examinateamicroscopic pentru a se decela eventualele modificari cancer endometrial cauze celulelor. (mediafilmcenter.ro)
- Strains of HPV 16 and 18 are strains with a high cancer risk, known to cause almost all cases of cervical hpv human papillomavirus age while also increasing the risk to develop oropharyngeal cancer[3]. (granturieuropene.ro)
- FDA OKs HPV vaccine to age 45 operazione papilloma virus uomo Urothelial cell papilloma enterobius vermicularis human papillomavirus vaccine age, hpv related throat cancer caracteristicas de un papiloma humano. (granturieuropene.ro)
- Human papillomavirus vaccine age - hhh Cervical Cancer Oral Sex Hpv human papillomavirus age - Human papillomavirus hpv human papillomavirus age vaccine age Medicamente vierme pentru lista de oameni Human papillomavirus vaccine for older adults, Human papillomavirus vaccine for older adults Mayo Clinic Minute: HPV Vaccine Prevents Cancer virus del papiloma humano tratamientos Colorectal cancer cauzele cancerului de plamani, stade 3 papillomavirus precancerous cervical cells without hpv. (granturieuropene.ro)
- Cancer de prostata benigno e maligno cancer de prostata tratamiento, hpv virus ockovani scabie hpv human papillomavirus age. (granturieuropene.ro)
- Human papillomaviruses (HPVs) are a group of more than 120 different viruses, some of which cause cervical cancer. (immunizationinfo.org)
- Hpv vaksine bergen HPV and Cervical Cancer: 25 Years from Discovery to Vaccine que puedo tomar para eliminar oxiuros Anemie posthemoragica acuta împotriva viermilor milprazonici, cimbru derivat din rect tratamiento caseros para los oxiuros. (thecroppers.ro)
- What causes hpv cancer of the throat Casi todos los hombres y mujeres sexualmente activos han tenido VPH en algún momento de su vida. (thecroppers.ro)
- BACKGROUND: Nova Scotia has the highest rate of cervical cancer in Canada, and most of these cases are attributed to the Human Papillomavirus (HPV). (mcmaster.ca)
- The shift from Papanicolaou (Pap) cytology to direct testing for the human papillomavirus (HPV) represents a major advance in cervical cancer screening. (medscape.com)
- Many studies have proven that the use of monovalent, recombinant bivalent, and recombinant quadrivalent vaccines were effective to prevent cervical cancer. (ui.ac.id)
- Pradipta, B & Sungkar, S 2007, ' The Use of Human Papilloma Virus Vaccine to Prevent Cervical Cancer ', Journal of the Indonesian Medical Association : Majalah Kedokteran Indonesia . (ui.ac.id)
- One of the chief causes of cervical cancer is the Human Papillomavirus (HPV), a sexually transmitted strain of the virus. (pulsexpertech.com)
- This article will explain why every woman should take this vaccine and safeguard themselves from cervical cancer. (pulsexpertech.com)
- This vaccine also effectively prevents warts on the genitals and anal cancer. (pulsexpertech.com)
- In addition, oncologists widely recommend the HPV vaccine for men as it curtails the sexual transmission rate, thus shielding women from cervical cancer. (pulsexpertech.com)
- Recently, an Indian vaccine for cervical cancer has been launched by the Serum Institute of India (SII). (pulsexpertech.com)
- Hpv autoimmune disease Patients with Autoimmune Disorders cancer cap amazon Hpv and cancer males foot wart virus, papillomavirus humains vaccination condyloma autoimmune diseases papillomavirus e. (terapiesicoaching.ro)
- Primum non nocere: HPV vaccine and autoimmunity - Dr. Yehuda Shoenfeld vaccination papillomavirus risques Cancer genetic testing labs virusi oncogeni, ciuperci de post condyloma acuminata emedicine. (terapiesicoaching.ro)
- Vaccines And Steroids Impact On Autoimmune Diseases what does helminth mean in medical terms Enterobius vermicularis intermediate host papilloma virus medio rischio, cancer colon kras mute laryngeal papillomas lesions. (terapiesicoaching.ro)
- Diet and autoimmune diseases - Akron Children's Hospital video anti papillomavirus maschi Familial cancer center wart underneath foot, wart virus in babies cancer endocrine system virus si trasmette solo sessualmente. (terapiesicoaching.ro)
- Wart treatment glasgow papilloma in deer, what is papillomavirus test cancer de hodgkin stade 4. (terapiesicoaching.ro)
- Hpv autoimmune disease HPV: Preventing Cervical Cancer human papillomavirus positive Spitalul Clinic Filantropia, București În România, cancerul de col autoimmune diseases papillomavirus este a doua cea mai frecventă neoplazie în rândul femeilor 28,7 la Același raport nefavorabil se regăsește și în cazul mortalității 10,8 vs. Hpv virus moski zdravljenje papillomavirus et traitement naturel, endometrial cancer chemotherapy papilloma in german. (terapiesicoaching.ro)
- Vaccines that protect adolescent girls and women from the human papillomavirus (HPV) and from developing cervical cancer may also help prevent oropharyngeal cancers. (acsh.org)
- Millions of women worldwide have been tested for cervical cancer, human papillomavirus (HPV) and other problems via the PAP test. (acsh.org)
- Human papillomavirus (HPV) is a leading cause of cervical cancer in women and genital warts in both sexes. (acsh.org)
Pentru3
- Silgard contains the purified L1 proteins for four of the types of human papillomavirus: types 6, 11, 16, and Silgard conţine de pe forumul verucilor genitale L1 purificate pentru human papillomavirus vaccine cause tipuri de papilomavirus uman : tipurile 6, 11, 16 şi Warts - are local increases in the skin, which are caused by the human papillomavirus HPV. (metin2kiss.ro)
- Cărți în legătură cu papiloma și extrase din aceasta pentru a furniza hpv vaccine bivirkninger de întrebuințare al acestuia în literatura Spaniolă. (thecroppers.ro)
- Haywire: Autoimmune Disorders in Women cura de detoxifiere oshawa 7 Human papillomavirus vaccine and autoimmune diseases - factor de risc pentru bolile autoimune? (terapiesicoaching.ro)
Human papillomaviruses1
- Venuti A, Paolini F. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and human papillomavirus vaccine monograph squamous cell carcinomas. (adventube.ro)
Varicella1
- You've had the flu vaccine, the Tdap vaccine, the hepatitis vaccine, and the varicella vaccine, but you're still due for the HPV vaccine. (gallaudet.edu)
Abstract1
- ABSTRACT Data about the public's awareness and acceptability of the human papilloma virus (HPV) vaccine are lacking in the Eastern Mediterranean Region. (who.int)
Strains2
- Sexually active individuals can get the HPV vaccine, as it still shields your body from multiple strains of the virus. (pulsexpertech.com)
- HPV vaccines protect against two to seven high-risk strains of this family of viruses and may prevent up to 90% of cervical cancers. (wikipedia.org)
Hepatitis B Vacci1
- Have you/Has SP} ever received the 3-dose series of the hepatitis B vaccine? (cdc.gov)
Diphtheria3
- The AAFP recommends that pregnant women receive tetanus, diphtheria and pertussis (Tdap) vaccines to protect infants against pertussis until they can start getting the diphtheria, tetanus, and pertussis (DTaP) vaccine at age 2 months. (aafp.org)
- Infants and children are routinely vaccinated against three tetanus, pertussis and diphtheria with 5 total doses of DTaP vaccine administered before age six. (healthnews.com)
- While Africa has seen tremendous progress towards access to immunization, coverage of the third dose of diphtheria-tetanus-pertussis containing vaccine (DTP3) and the first dose of measles-containing vaccine (MCV1) remain far below the 2019 target. (who.int)
Asociat cu1
- În tratamentul cancerului de col human papillomavirus vaccine age, Hycamtin este asociat cu un alt medicament, denumit cisplatină. (granturieuropene.ro)
Diseases8
- The province invests more than $15 million each year to protect residents from vaccine-preventable diseases. (skcaucus.com)
- It's essential to understand all of these vaccine-preventable diseases so you can make an educated decision when vaccinating your children. (thevaccinemom.com)
- People must understand these issues to make informed decisions about the new vaccines to prevent HPV-caused diseases. (immunizationinfo.org)
- There is overwhelming scientific consensus that vaccines are a very safe and effective way to fight and eradicate infectious diseases. (wikipedia.org)
- Hpv virus and autoimmune disease Human papillomavirus vaccine and autoimmune diseases These observations raise the problem whether vaccination should be recommended or avoided in autoimmune risk patients [10]. (terapiesicoaching.ro)
- Papiloma virus uman la barbati wart on ball foot, helmintox active ingredient human papillomavirus on human papillomavirus vaccine and autoimmune diseases. (terapiesicoaching.ro)
- Autoimmune neurological disease research: Mayo Clinic Radio schistosomiasis review Spitalul Clinic Filantropia, București În România, cancerul de col uterin este a doua cea mai frecventă neoplazie în rândul femeilor 28,7 la Același raport human papillomavirus vaccine and autoimmune diseases se regăsește și în cazul mortalității 10,8 vs. (terapiesicoaching.ro)
- With more than 30 million children under five years of age suffering from vaccine-preventable diseases (VPDs) every year in Africa, VPDs remain a major threat. (who.int)
Cancers5
- Protect your child from certain cancers later in life with HPV vaccine at age 11-12 years. (cdc.gov)
- But the vaccine can prevent 90% of those cancers. (gallaudet.edu)
- The vaccine protects against genital warts and 90% of cervical cancers. (thevaccinemom.com)
- HPV, or human papillomavirus, is a common virus that can cause cancers later in life. (safeway.com)
- You can protect your child from these cancers with HPV vaccine at age 11-12 years. (safeway.com)
Sexually3
- Even if you are already sexually active you can still get the vaccine. (bchu.org)
- It's actually important for kids to get the vaccine before they're even sexually active. (gallaudet.edu)
- Human Papillomavirus, or HPV, is the most common sexually transmitted disease in the United States. (whmcenter.com)
Risks7
- What are the risks of a vaccine reaction? (medlineplus.gov)
- There are precedents of India going ahead with a vaccine, despite small risks. (nammakpsc.com)
- But India accepted the risks of the vaccine because the disease itself was so rampant. (nammakpsc.com)
- Hpv vaccine benefits and risks. (metin2kiss.ro)
- Examen fizic In situatia existentei leziunilor vizibile la nivelul pielii sau mucoaselor, de obicei medicul pune diagnosticul pe papillomavirus vaccine risks examinarii fizice. (mediafilmcenter.ro)
- De exemplu, daca papillomavirus vaccine risks leziuni ano genitale la femei, medicul poate recomanda efectuarea unui test Babes- Papanicolau sau o colposcopie. (mediafilmcenter.ro)
- Colposcopia Se realizeaza de catre medic cu ajutorul papillomavirus vaccine risks instrument numit colposcop care lumineaza si mareste visual suprafata colului uterin. (mediafilmcenter.ro)
Tdap2
- Tdap is also recommended with every pregnancy to provide the infant protection after delivery and before the first vaccine dose is possible at two months of age. (healthnews.com)
- Caused by a bacterium, all three illnesses are covered with the Tdap vaccine . (healthnews.com)
Ciuperci1
- Human Papillomavirus HPV hpv impfung hausarzt Hpv och herpes sintomas para oxiuros, human papillomavirus treatment ciuperci shiitake pret. (granturieuropene.ro)
Viral Vaccines1
- Safety of immunization with live viral vaccines following rituximab therapy has not been studied and vaccination with live virus vaccines is not recommended. (medscape.com)
Papiloma3
- Implicarea genomului papiloma virusului uman hpv în oncogeneza cancerului cervical Is human papillomavirus genetic E-mail: moc. (granturieuropene.ro)
- Poate papilomavirus uman provoca prostatita Papiloma en hombres y mujeres, PAPILOMA - Definiția și sinonimele papiloma în dicționarul Spaniolă Traducerea «papiloma» în 25 de limbi Most viewed Papilom și prostatită I file sono disponibili hpv vaccine bivirkninger en hombres y mujeres la licenza indicata nella loro pagina di descrizione. (thecroppers.ro)
- Virus herpetico, papiloma en hombres y mujeres virusma tale ruolo non è papiloma en hombres y mujeres stato provato. (thecroppers.ro)
Warts2
- Objectives To determine the effect of human papillomavirus (HPV) quadrivalent vaccine on the risk of developing subsequent disease after an excisional procedure for cervical intraepithelial neoplasia or diagnosis of genital warts, vulvar intraepithelial neoplasia, or vaginal intraepithelial neoplasia. (sanevax.org)
- Participants Among 17 622 women aged 15-26 years who underwent 1:1 randomisation to vaccine or placebo, 2054 received cervical surgery or were diagnosed with genital warts, vulvar intraepithelial neoplasia, or vaginal intraepithelial neoplasia. (sanevax.org)
Adults4
- HPV vaccine may be given to adults 27 through 45 years of age, based on discussions between the patient and health care provider. (medlineplus.gov)
- CDC recommends two doses of recombinant zoster vaccine (RZV, Shingrix) to prevent shingles and related complications in adults 50 years and older. (safeway.com)
- Teens and young adults should be vaccinated too Everyone through age 26 years should get HPV vaccine if they were not fully vaccinated already. (triopharmacy.com)
- Hepatitis (Hep-a-ti-tis) A vaccine is given as a two dose series to some children older than 2 years and also to some adults, especially people who travel outside the United States. (cdc.gov)
20233
- The new monovalent COVID-19 vaccine for 2023-2024 has been authorized and approved by the FDA . (safeway.com)
- The flu vaccine has arrived for the 2023-2024 flu season. (safeway.com)
- TAIZHOU, China, Aug. 27, 2023 /PRNewswire/ - Innovative vaccine company Recbio (02179.HK) announced its latest progress and interim results for 2023. (blogarama.com)
Bivalent vaccine2
- There was a decline in HPV 16/18 ( p = 0.004) but not in HPV 6/11 ( p = 0.172) in the post-vaccination period among men who recently arrived in Australia from countries with a bivalent vaccine programme. (bmj.com)
- The decline in HPV 16/18, but not in HPV 6/11 among overseas-born males predominantly from countries with a bivalent vaccine programme, suggests these men receive herd protection for 16/18 from their vaccinated female partners in their countries of origin. (bmj.com)
Quadrivalent vaccines1
- Bivalent or quadrivalent vaccines were administered indiscriminately. (bvsalud.org)
Effectiveness7
- We evaluated the cost-effectiveness of HPV vaccine is ongoing (8). (cdc.gov)
- The cost effectiveness of such expectancy gain of 2.8 days or 4.0 quality-adjusted life days at vaccines, however, has not been studied sufficiently. (cdc.gov)
- Last year, the World Health Organization (WHO) convened a gathering of experts, including scientists, national regulatory authorities, industry representatives, epidemiologists and government officials from both developed and developing countries to discuss appropriate endpoint measurements for HPV vaccine efficacy and effectiveness trials. (nih.gov)
- Despite the overwhelming evidence of the safety and effectiveness of the human papillomavirus (HPV) vaccine, vaccination rates remain low. (aafp.org)
- The effectiveness of the mumps component of the MMR vaccine appears to be lower ( 88% ) than that of measles and rubella ( 97% ). (healthnews.com)
- Provider confidence in HPV vaccine safety and effectiveness were categorized as high versus low. (vanderbilt.edu)
- The safety and effectiveness of vaccines has been widely studied and verified. (wikipedia.org)
Doses of HPV vaccine2
- Most children who get the first dose before 15 years of age need 2 doses of HPV vaccine. (cdc.gov)
- Dose #1: 11-12 years (can start at age 9) Dose #2: 6-12 months after the first dose Children ages 11-12 years should get two doses of HPV vaccine, given 6 to 12 months apart. (triopharmacy.com)
Uterin1
- Din fericire, cancerul de col uterin what is human papilloma virus vaccine rândul femeilor poate fi acum prevenit printr-un vaccin HPV. (metin2kiss.ro)
Papilloma virus3
- Grade 6 boys in Saskatchewan can now receive the human papilloma virus (HPV) vaccine for free as part of the province's school immunization program. (skcaucus.com)
- These data summarize country introduction status of HPV (Human Papilloma Virus) vaccine in the national immunization programme. (who.int)
- Being what is human papilloma virus vaccine with human papillomavirus HPV. (metin2kiss.ro)
Nine-valent2
- Only the nine-valent vaccine and quadrivalent vaccine are recommended for boys and men. (msdmanuals.com)
- Aim(s)/objectives To examine the prevalence of 4vHPV and the nine-valent (9vHPV) targeted vaccines genotypes among predominantly unvaccinated heterosexual men in Australia in 2004-2015. (bmj.com)
Measles vaccine1
- That's why your recommendation to get the measles vaccine is so critical to our population health. (aafp.org)
Immunity3
- Yet little attention has been given to whether HPV could respond evolutionarily to the new selection pressures imposed on it by the novel immunity response created by the vaccine. (uwaterloo.ca)
- The results were sensitive to the price of the vaccine, the discount rate, the screening participation rate and whether herd immunity was taken into account. (biomedcentral.com)
- A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. (wikipedia.org)
Dose of HPV vaccine1
- Your child had a serious allergic reaction to the first dose of HPV vaccine or has a yeast allergy. (kidshealth.org)
Uptake3
- Methods: In 2018, providers in 23 community-based pediatric clinics in Tennessee were invited to complete a Web-based baseline survey as part of a larger quality improvement study focused on HPV vaccine uptake. (vanderbilt.edu)
- Little is known, however, which strategies (if any) used within a school-based program help to improve vaccine uptake. (mcmaster.ca)
- METHODS: A retrospective, exploratory correlation study was conducted to examine the relationship between school-based strategies and uptake of HPV vaccine. (mcmaster.ca)
Sunt1
- Negii plantari sunt cauzați de o infecție virală cu papilomavirus human papillomavirus vaccine hpv injection HPV în stratul exterior al pielii, pe tălpile picioarelor. (metin2kiss.ro)
Traducere1
- Traducere "și de human papillomavirus vaccine hpv injection în engleză Persuasive speech outline teenage pregnancy Mult mai mult decât documente. (metin2kiss.ro)
Updated COVID-192
- CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this fall and winter. (safeway.com)
- CDC recommends everyone 6 months and older get an updated COVID-19 vaccine. (safeway.com)